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Abstract 
The main aim of this thesis is to evaluate the Theory of Planned Behaviour's 
ability to identify predictors of intention and behaviour. The population of 
interest are heroin users; the behaviours are attendance at treatment services and 
heroin use during drug treatment. The thesis is divided into four broad sections. 
First, a literature review considers the impact of heroin use on the individual 
and society; the relevance of drug treatment to enable reductions of drug related 
harms and the predictors associated with poor treatment outcomes. It goes on to 
provide justification for the use of the TPB over other models of behaviour 
change and discusses the limitations associated with its application. The TPB is 
shown to be a useful predictor of behaviour and intentions in general, although 
there is no research considering the prediction of attendance for drug treatment 
and future heroin use. 
Secondly, a qualitative study explores whether the TPB is an appropriate 
framework for predicting behaviour in this population by undertaking interviews 
designed to investigate whether drug users can think about stopping drug use in 
relation to TPB constructs. A review of previous qualitative research and findings 
from this study suggest that the TPB would be an appropriate framework for use 
in this domain. 
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Thirdly, two studies provide data to support the usefulness of the TPB as a 
predictor of treatment attendance and heroin use intentions and behaviour. 
Evidence reveals the inclusion of clinical variables adds additional variance to the 
TPB; subjective norm is found to be a significant predictor of behaviour and the 
use of objective measures of behaviour provide further validation for the 
predictive ability of the TPB. Longitudinal data support the predictive validity of 
the TPB predictors over a three and six-month period. 
Finally, key findings from the thesis are discussed, as are limitations of the 
studies included. Future directions for research are suggested, concluding with a 
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Chapter 1- Predictors of Heroin Use Behaviour and Models of 
Behaviour Change 
1.1 Introduction 
1.1.2 The Impact of Heroin use 
Heroin use is illegal but none the less the use of heroin is widespread in 
many countries and the related harms impact not only on the individual but also 
on their families and society. 
The problems relating to heroin use are complex and entwined with risks 
resulting from the direct use of the drug, for example; intoxication, physical 
dependence, route specific dangers, and drug associated risks; psychological and 
social problems, blood borne viruses and criminal involvement. Chronic 
dependant use of heroin use can further increase the risk of social exclusion, 
heroin related morbidity and drug related deaths (Department of Health 2001). 
Drug treatment is seen as an effective way to reduce drug related problems 
and mortality (Gibson et al 2008) yet for many heroin use does not stop with the 
start of treatment with a significant proportion continuing to use illicit drugs 
regularly and failing to respond to drug interventions (Best & Ridge 2003) 
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1.1.3 A National Drug Strategy 
The UK's Updated National Drug Strategy (Home Office 2002a) pays 
particular attention to targeting class A substances, in particular heroin and crack- 
cocaine, one of the aims being to enable problem drug users to access treatment. 
It is estimated that for every EI spent on treatment, at least E9.50 is saved in crime 
and health costs (Home Office 2002a), suggesting that getting drug users into 
treatment is the best way of improving their health and ability to lead fulfilling 
lives. 
Due to the nature of risk associated with illicit drug use the National 
Treatment Agency for Substance Misuse (NTA, a special Department of Health 
Trust) sets targets to ensure that drug users wanting treatment are able to access 
this as quickly as possible and be retained in treatment for a sufficient period that 
they may experience long-term benefit (NTA 2006). 
1.1.4 Drug Treatment 
The aim of treatment is to reduce drug related harm, reduce the amount of 
illicit substances used and ultimately achieve abstinence. Treatment services offer 
individuals with opiate dependency the opportunity to access replacement 
treatments as an alternative to illicit drug use. 
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Methadone, a synthetic opioid agonist', and buprenorphine, a mixed 
antagonist-agonis? synthetic opioid, are the most popular choices for drug 
treatment. Though methadone is the most widely used and researched, treatment 
for opiate dependency, buprenorphine has been found to be at least as effective as 
methadone as a maintenance treatment (West, O'Neal & Graham 2000). 
Heroin substitutes, methadone and buprenorphine, are seen to be 
successful in reducing physical withdrawal states and offer positive outcomes in 
terms of reductions in drug use, injecting risk behaviours, improved social and 
psychological functioning (Barnett, Rodgers & Bloch 2001, Mattick et al 2003). 
Used as maintenance treatments, whereby constant doses of medication are given 
to suppress opiate withdrawal, over the medium to long-term, or as reduction 
programmes with the expectation that the dose will gradually reduce and the 
individual will be withdrawn from and become abstinent from prescribed drugs 
(Seivewright 2000). Drug treatment also incorporates the management of acute 
opiate withdrawa13 (Gowing, Ali & White 2000), though post-treatment outcomes 
of acute opiate withdrawal are often poor, in comparison to maintenance 
outcomes, with treatment drop out or continued heroin use common (Horspool et 
al 2008). 
1 Agonist; a drug that binds to receptor cell triggering a response i. e. produces an opiate effect 
similar to that of heroin. 
2 Antagonist-agonist; drug that binds to a receptor cell triggering a response but that also inhibits 
further cell triggering i. e. produces an opiate effect but stops any subsequent opiate drug binding at 
the receptor, hence any additional opiates used will be ineffective. 
3 Opiate withdrawal programmes, or detoxification, are used to alleviate the acute symptoms of 
withdrawal from dependent drug use with the aim of abstinence, usually conducted over a much 
shorter time period than reduction or maintenance treatments. 
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Drug treatment can be effective in reducing drug use and other problem 
behaviours but despite this a proportion of drug users in treatment continue to use 
illicit drugs and estimates of continued drug use during treatment range from 
between 20% and 70% (Best & Ridge 2003, Belding et al 1998) 
1.1.5 Drug Treatment Outcomes 
Treatment services are not identical in their structure and operation and 
outcome studies show that the level of effectiveness varies widely with most 
services monitoring their own outcomes (Marsden, Gossop & Stewart 2003). The 
National Treatment Outcome Research Study (NTORS) investigated outcomes 
among drug users attending 54 treatment services across the UK. Generally, 
patients receiving medical treatment, methadone in particular, have shown some 
reductions in heroin and other drugs at 6-months (Gossop et al 1997), and at 4-5 
year follow-up (Gossop et al 2003). Consequently, attracting drug users into and 
retaining them in treatment is a high national priority (Home Office 2002a). 
Studies of treatment outcomes generally focus on the ability of the 
treatment under investigation to reduce or improve pre-treatment variables. Few 
studies report or suggest the reasons for non-compliance with treatmený 
continued drug/alcohol use and the pre-treatment variables that could be 
predictive of poor treatment outcomes and ongoing drug use. Thus limiting the 
ability to identify those most at risk, at the outset of drug treatment. 
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1.2 Predictors of Continued Drug Use 
Ongoing drug use and drug use during treatment presents a challenge to 
clinicians and in order to meet the challenge most effectively, the variables that 
predict continued drug use must first be identified. Several treatment outcomes 
studies report that ongoing drug use is a strong predictor of poor treatment 
compliance (Gossop, Duncan & Marsden 2003) and treatment dropout altogether 
(Booth, Crowley & Zhang 1996). 
Brewer et al (1998) conducted a meta-analysis of predictors of continued 
drug use during and after treatment for opiate addiction. The review included 69 
studies from which 28 independent variables were identified. The results found 
that none of the variables included in the study were strongly predictive of 
continued drug use. Those variables with weak to moderate associations with 
continued drug use are heavy pre-treatment drug use, prior treatment episodes, 
association with other drug users, short treatment episodes and those that dropped 
out of treatment. In addition stress/life events were also mildly positively 
associated with continued drug use (Brewer et al 1998). 
These results are also fairly consistent with an earlier review conducted by 
Alemi et al (1995). The main differences being in the study by Alemi et al (1995) 
poly-drug use and criminal behaviour were moderately predictive of continued 
heroin use but these same variables showed a weak association in the Brewer et al 
(1998) analysis. As these meta-analyses are over a decade old, the following 
sections under the headings; (i) demographics, (ii) family and peer influence, (iii) 
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pre-treatment drug use, (v) criminal behaviour and legal problems and (v) 
treatment history, are up dated with more recent outcome studies to identify 
consistent results or highlight any additional variables that may be significant 
predictors of continued drug use during treatment. 
1.2.1 Demographics 
Drug users who are younger, single and have no permanent residency tend 
to experience poorer treatment outcomes (McLellan et al 1994; Moos, Nichol & 
Moos 2002). Whilst those who are unemployed are more likely to continue to use 
drugs than those in employment though Brewer et al (1998) suggests that the 
research in this area is conflicting. 
There is some evidence that gender per se has little bearing on continued 
drug use during treatment (Moos, Nichol & Moos 2002) but the influence of 
sexual partners on their drug use can effect the outcome of treatment process. 
Women with drug using partners can be 5 times more likely to use drugs 
compared with women whose partner is a non-drug user (Tuten & Jones 2003). 
Anglin et al (1987) indicate that women may benefit more from having their 
partner in treatment with them. 
1.2.2 Family and Peer Influences 
Moderate associations were found by Brewer et al (1998) with regards to 
continued drug use and other drug users and that association with other drug using 
peers is a strong indication of ongoing drug use. 
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Schroeder et al (2001) found peer drug use to be the strongest predictor of 
continued drug use above drug treatment and demographic variables. At one-year 
follow-up 69% (236) of participants associating with drug using peers were still 
using drugs on a daily basis. Termorshuizen et al (2005) also found higher rates 
of ongoing heroin use during methadone treatment in individuals who associated 
with other drug users or had drug using partners. 
1.2.3 Pre-treatment Drug Use 
Brewer et al (1998) found moderate associations with continued drug use 
in participants in treatment with a long history of opiate use. Also those 
individuals that began using at an early age were more likely to continue using 
illicit drugs during treatment than those with shorter histories or late onset drug 
use. 
Gossop, Duncan and Marsden (2003) reported that the strongest predictor 
of heroin use at 6 months is heroin use at I month and participants that dropped 
out of treatment and were lost to follow-up were more likely to be opiate injectors 
that also injected cocaine. The frequency of intravenous use and crack smoking 
was also higher in the participants that dropped out (Booth, Crowley & Zhang 
1996). Best et al (1999) suggests that opportunistic drug users are more likely to 
use drugs during treatment than those using drugs purely to stop physical 
withdrawals. 
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Factors associated with 12-month heroin abstinence was investigated by 
Darke et al (2005) and they report that abstinent participants (14%) were more 
likely to have been classed as 'treatment ready', had no previous treatment 
history, have used heroin less frequently at baseline and less likely to have been 
daily injectors or using crack-cocaine. 
1.2.4 Criminal Behaviour and Legal Problems 
Legal status and ongoing criminal involvement have concurrent positive 
associations with continued drug use (Brewer et al 1998) and low rates of criminal 
involvement are reported by Darke et al (2005) as being correlated with improved 
rates of abstinence. This is in contrast to Moos, Nichol and Moos (2002) who 
reported no significant differences in continued drug use between those attending 
treatment a voluntary basis or those mandated to treatment by the criminal justice 
system. 
1.2.5 Treatment History 
Hser et al (1999) found relatively poor outcomes among treatment- 
experienced patients, which were related to increased urimet need, and less 
compliance with treatment than those entering treatment for the first time 
(supported by Brewer et al 1998, Darke et al 2005). Those with no prior periods 
of abstinence were also more likely to continue using (Brewer et al 1998). 
Distance was also a factor for attendance, with those travelling the furthest more 
likely to discontinue treatment (Beardsley et al 2003). 
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1.2.6 Summary of Findings 
The reported literature on predictors of ongoing drug use and treatment 
attrition is somewhat inadequate. The above examples, including two meta 
analyses (Alemi et al 1995, Brewer et al 1998), report no consistent drug or 
treatment variables that are predictive of continued drug use over numbers of 
studies hence the body of evidence needed in which to build models that identify 
those at most risk is poor. The implication of this being that drug treatment 
services are really stabbing in the dark when it comes to allocating resource and 
focusing intervention on behaviour change when those individuals most likely to 
have the worst outcomes cannot be identified at the outset of treatment. 
One reason could be that drug treatment studies, from which we gather the 
evidence base, report different outcome measures. Brewer et al (1998) identified 
28 independent variables, ranging from 71% to 7% consistency across measures. 
Those variables most commonly reported were demographics, for example, age 
(61%), Gender (64%), ethnicity (71%), and employment (53%). Duration of drug 
use and treatment completion was reported by 53% and 61% respectively. 21 out 
of the 28 variables identified by Brewer et al (1998) reported lower than 20% 
consistency across studies, for example pre-treatment levels of heroin use was 
only reported by 6 out of 28 studies (20%) included in the meta-analysis. 
Interestingly those variables most frequently reported are not significant 
predictors of ongoing drug use hence treatment outcome studies are potentially 
missing important features of ongoing drug use. One category missed by all the 
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studies included in this section is psychological variables and the impact attitudes 
and cognitions may have on drug treatment outcome. 
1.3 Psychological Determinants of Drug Use 
Gossop, Duncan and Marsden (2003) suggest treatment involves more 
than just attending treatment sessions it also requires the active participation of 
the client and may be regarded as having both an objective component (e. g., 
amount of therapeutic contact) and a subjective component (e. g., cognitive 
involvement, motivation for treatment). 
Davies (1992) suggests that people use drugs for their own reasons, for 
example, because they like it or have no reason to stop and that when asked about 
their use of drugs by researchers or treatment services it is functional for them to 
report that they are 'addicted', compelled to use due to withdrawals and driven 
into drug use by forces out of their control. Thus treatment services view heroin 
users as helpless drug addicts and consequently present themselves to treatment 
services with that agenda3. Hence, engaging drug users into prescribed treatment 
is only part of the picture, Pendergast et al (2002) raises the question of how the 
treatment process can be improved. 
3 Davies' (1992) application of attribution theory examines the way in which people explain why 
things happen. The basis of attribution theory is the desire to understand how people arrive at 
explanations for their own and for other people's behaviour (Heider 1958). See Davies' (1992) 
"Myth ofAddiction" for his application of this theory to illicit drug use and how attributions can 
change across the course of 'addiction'. 
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Surprisingly little is known about the process of treatment as it is actually 
delivered (Pendergast et al 2002) and research attention to the associations and 
interactions between patient characteristics, cognitions and treatment variables are 
limited. In view of what Davies (1992) might be suggesting cognitive predictors 
should be viewed as an important aspect of treatment outcome. As discussed, few 
studies have been identified that examine individuals' cognitions and behaviour to 
examine whether this is a determinant of continued drug use during treatment. 
Models of behaviour change seem to have been neglected in this area. 
Psychosocial variables such as attitudes and motivation may provide a 
more direct assessment of behaviour and be more amenable to change. Attitudes 
and beliefs about the outcomes of behaviour are central to social cognition 
models. The following section will review and assess the efficacy of utilising a 
psychosocial framework for predicting ongoing heroin use. By understanding the 
psychological determinants of heroin use during treatment the development of 
interventions, aimed at modifying cognitions, could help improve outcomes. 
1.4 Models of Behaviour Change 
Numerous models of health behaviour exist and this section will review 
those models that have been specifically applied to drug using populations to 
assess the applicability of their use as a framework to predict heroin behaviour. 
25 
Database searchee resulted in limited application of health behaviour 
models to drug use, retrieving only two models had been specifically applied to 
drug using populations; the Transtheoretical Model (Prochaska & DiClemente 
1986; TTM) and the Theory of Planned Behaviour (TPB; Ajzen 1991). The 
remainder of this section will concentrate only on reviewing these two models, as 
no baseline evidence exists for the application of other models. 
1.4.1 The Transtheoretical Model 
The transtheoretical model (TTM; Prochaska & DiClemente 1986), 
originally developed for smoking cessation, specifies five stages that people move 
through on their journey of behaviour change (see Figure 1): precontemplation 
(not considering change), contemplation (considering change in the future), 
preparation (planning to change), action (has made changes) and maintenance 
(maintained change over a prolonged period of time - usually 6 months). There 
are ten processeS5 that facilitate the progression through these stages of change 
(Prochaska & Velicer 1997) and the different stages are associated with different 
belieO. The model also includes a relapse phase which can happen at any time 
resulting in the individual moving back into an earlier stage; this cycle may be 
4 Database searches included Web of Knowledge/Web of Science, Medline, Pubmed, CMAHL, 
Psyclit and hand searches of meta-analysis. Word searches included the specific behaviour change 
models, i. e., transtheoretical model or stage of change model, and 'illicit drugs' 'substance use' 
'heroin' 'opiates' 'methadone' 'crack-cocaine' 'cocaine' 'ecstasy' 'amphetamine' 'LSD' and 
'cannabis'. Consideration could be given to extending this search to other addictive behaviours 
for example alcohol or smoking however, the rationale for limiting this to drug use was to examine 
whether an evidence base exists for application of social cognitive models to illicit drug using 
behaviours as this is the main focus of the thesis. 
5 The 10 processes of change; consciousness raising, counter conditioning, dramatic relief, 
environmental re-evaluation, helping relationships, reinforcement management self liberation, self 
evaluation, social liberation and stimulus control. 
6 Decisional balance and self-efficacy: namely the assessment of the pros and cons of the 
behaviour and the self-corif idcnce in the ability to change. 
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repeated several times before someone achieves successful long-term behaviour 
change (Prochaska & DiClemente 1986). Hence, progression through the stages 
is viewed as cyclical rather than linear. 
The majority of research on the TTM and substance misuse has centred on 
the classification of individuals according to their stage of change with few 
studies focusing on the actual process of change (Migneault, Adams & Read 
2005). 
1.4.1.1 TTM Applied to Drug Use 
A recent study by Gossop, Stewart and Marsden (2006) tested the 
application of the TTM and its ability to predict drug use over time based on stage 
of change. One thousand and seventy five opiate users seeking drug treatment 
were recruited, with 753 (70%) of those individuals followed up at I-year. A 
multiple regression analysis was conducted and results were unable to find any 
significant associations between the readiness for change measures and drug use 
outcomes. The strongest predictor of drug use at follow-up was drug use at 
intake. 
Velasquez et al (2000) assessed stage of change in a population of 
homeless people in an attempt to learn more about the drug treatment needs of 
these individuals. Basic analysis revealed that drug usere were again 
predominantly allocated to precontemplation and contemplation stage (30% and 
7 The primary drug used was crack-cocaine (69%) followed by marijuana (64%), powder cocaine 
(I 81/o) and heroin (7%) though results are amalgamated to include all drug types. 
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60%). This study reports that the use of this measure was helpful in highlighting 
the specific stage of change but was not longitudinal so effectiveness of the 
measure of stage recognition over time cannot be established. 
Figure 1.1: The Transtheoretical Model 
Precontemplation 
Not considering change 
Contemplation 
Considering change in the future 
Preparation 
Planning to change 
Action 




Maintained change - usually over 6-months 
1.4.1.2 Limitations within the TTM 
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Results from studies examining the stage and processes of change have 
yielded inconsistent findings, mixed results for the validity of the TTM constructs 
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and a wide variability in measurement of stage of change constructs8 (Migneault, 
Adams & Read 2005). Hence, it has been questioned whether the model 
provides, in its current form, a valid description of the process of change and 
research based upon it has been criticised (Sutton 2001). West (2005) argues that 
there are such serious problems with the stage-based model that it should be 
disregarded and that a replacement is needed that more accurately reflect 
observations about behaviour change. The TTM model may possess good 
descriptive validity but it is currently lacking in predictive validity hence an 
alternative health behaviour model may be more effective in predicting 
behaviours. The Theory of Planned Behaviour (TPB Ajzen 199 1) for example. 
Armitage and Arden (2002) found that theory of planned behaviour, 
particularly behavioural intention, was predictive of TTM stage and report that the 
TTM is a 'pseudo-stage model'; thus the model adds little beyond what is 
presented in the TPB and purport that in enabling behaviour change it might be 
more effective to target an intervention at an individual's intention to change 
rather than allocate to descriptive stages of change. The theory of planned 
behaviour, developed from the theory of reasoned action (TRA; Fishbein & Ajzen 
1975), has been utilised as a predictive framework for many health related 
behaviours (see Armitage & Conner (2001) for a full review). 
a Two main methods are used to measure stage of change; staging algorithms and multi- 
dimensional questionnaires. Belding, Iguchi & Lamb (1996) assessed the convergent validity of 
two measures in a population of methadone patients and report low concordance suggesting the 
two may well be measuring different aspects of readiness to change. 
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1.4.2 The Theory of Reasoned Action 
The theory of reasoned action (TRA) was designed by Fishbein and Ajzen 
in 1975, to predict behaviours under volitional control. The central component of 
the TRA is based around an individual's intention to perform a given behaviour. 
Behavioural intention is viewed as the motivation needed to engage in a particular 
behaviour and is an indication of how hard someone is willing to try in order to 
perform that behaviour (Fishbein & Ajzen 1975). Generally it is assumed the 
greater the intention to engage in the behaviour in question, for example to stop 
using drugs, the more likely you are to carry that behaviour out. 
The TRA purports that intention is a function of two independent 
determinants, attitude (positive or negative evaluations of the behaviour) and 
subjective norms (perceived social pressure from others). In addition, each 
determinant is underpinned by salient beliefs about that behaviour; attitude is 
determined the beliefs about the likely outcomes and the evaluation of these 
beliefs (behavioural beliefs), subjective norm is determined by the normative 
expectations of others and the motivation to comply (normative beliefs). 
Thus, the more positive your attitude towards a behaviour and the more 
perceived social pressure you feel from others to carry out that behaviour the 
stronger your intention will be to perform. However, the TRA fails to account for 
behaviours that are not fully under volitional control and hence those behaviours 
that may seem non-rational or not under complete control, drug use for example, 
may not adequately be explained by the TRA. 
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1.43 The Theory of Planned Behaviour 
The theory of planned behaviour (M) was developed to broaden the 
applicability of the TRA by incorporating perceptions of control. Perceived 
behavioural control (PBC) refers to the degree to which an individual feels that 
the performance of the behaviour is under their control as such constitutes a 
determinant of intention; thus the easier a behaviour the more likely you will 
intend to perform it. 
As with attitude and subjective norm constructs, salient beliefs underpin 
perceived behavioural control. Control beliefs are related to factors that may 
facilitate or impede performance of the behaviour and the strength of those 
factors. Hence the more in control you feel about performing the behaviour the 
more likely your intention to carry it out 
PBC is also regarded as a determinant of behaviour based on the notion 
that, if intention is held constant, greater perceived control will increase the 
likelihood that the behaviour will be performed (Ajzen 1991). For example, two 
people may both have equally strong intentions to stop using drugs but if one has 
more confidence in their ability then they are more likely to achieve the desired 
behaviour. According to Ajzen (1991), if perceived behavioural control reflects 
actual control this too can directly influence behaviour. 
Salient beliefs play a central role in the theory of planned behaviour. They 
are believed to provide the cognitive and affective foundations for attitudes, 
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su. ective norms and perceived behavioural control. Thus salient behavioural 
beliefs are assumed to determine attitude towards the behaviour, salient normative 
beliefs are assumed to determine subjective norms and salient control beliefs are 
held to determine perceived behavioural control. 
The TPB stipulates that the salient beliefs of an individual are the 
psychological determinants of behaviour operating through TPB constructs 
(Ajzen & Fishbein 1980). Therefore if the identified beliefs can be successfully 
targeted attitude change and consequent behaviour change can occur. 
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1.4.3.1 Application of the TPB 
The TPB has been extensively applied to predict intentions and behaviour 
across a range of health and non-health domains for example; health screening 
(Michie et al 2004, Rutter 2000), exercise behaviour (Armitage 2005), parasuicide 
(O'Connor, Armitage & Gray 2006) driving behaviour (Elliot, Armitage & 
Baughan 2007), access to service provision (Christian & Armitage 2002), binge 
drinking (Norman & Conner 2006) and drug using behaviours (Armitage et al 
1999, McMillan & Conner 2003), all of which support the application of the TPB 
in the prediction of intention and behaviour. 
In a meta-analysis of the TPB by Armitage and Conner (2001), across 
185 independent studies, attitude, subjective norms and perceived behavioural 
control accounted for 39% of the variance in intention whilst, across 63 studies, 
intentions and perceived behavioural control accounted for 27% of the variance in 
behaviour. This is encouraging and suggests that the TPB is a useful predictive 
model across a wide range of behaviours it; however, should be noted that only 
34% of the studies reviewed within the meta-analysis reported the prediction of 
behaviour with the majority focusing on the prediction of intention only. Further 
limitations within the TPB will be addressed in the following section. 
1.43.2. Limitations within the TPB 
1.4.3.2.1 Self-Reported Behaviours 
As mentioned in the previous section only 34% (n7-63) of studies included 
in the meta-analysis by Armitage and Conner (2001) included the prediction of 
behaviour. Further, of those 63 studies, only 19 studies used objective measures 
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of behaviour and results showed that there was a marked difference between 
studies employing self-report and objectively measured behaviours. Intentions 
and perceived behavioural control accounted for 20% variance on objective 
behaviour (across 19 studies), compared to 31% variance in self-reported 
behaviour (across 44 studies). Thus this brings into question the reliability of the 
TPB and undermines the power of the TPB to predict actual behaviour. 
Although self-reported behaviour is recognised as valuable it can lead to 
biases of both under and over reporting as well as self-prescntational biases 
(Paulhus 1984). Such biases may be particularly important for deviant or 
undesirable behaviours whereby giving information that might be seen as 
favourable to others. Elliott, Armitage and Baughan (2007) utilised both 
subjective and objective behaviour measures and whilst the TPB was better 
equipped to predict self-reported behaviour (R 2= . 62), the variance in observed 
behaviours ranged from 31%-39% which are greater than the values found in 
Armitage and Conner (2001) suggesting that the TPB is able to predict, with large 
effect (Cohen 1988), objective behaviours. Thus, the addition of objective 
measures of behaviour should be, where possible, included in TPB applications to 
improve reliability. 
1.4.3.2.2 Follow-Up 
A further limitation of the TPB has been the lack of prospective designs; 
hence the predictive validity of the TPB over time has not been greatly examined. 
The TTM (Prochaska & DiClemente 1986) posits that for behaviour change to 
occur, and be maintained, a period of six-months is required (see Section 1.4.1). 
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Thus, anything less than this is not seen as sustained behaviour change. Armitage 
et al (1999), for example, applied the TPB to predict legal and illegal drug use 
with a follow-up of just one-week, the same follow-up period was also employed 
by Norman and Conner (2006) to predict future binge drinking behaviour. Thus 
the TPB is significantly limited in its predictive ability by the use of such short 
follow-ups. 
Prospective designs of the TPB have been used though limitations are still 
apparent. O'Connor, Armitage and Gray (2006), examined the TPB over a three- 
month period in the prediction of parasuicide behaviour. Unfortunately study 
attrition resulted in only 26% of participants completing data collection at time 
two. Similar attrition rates were found when McMillan and Conner (2003) 
applied the TPB over six-months, to predict drug use, with only 29% of 
participants followed up at six months. The use of longitudinal studies of 
behaviour change is important to ensure the predictive validity of such models as 
the TPB. If longitudinal designs are to be employed, consideration of retention 
strategies or ways of dealing with missing data, for example imputing (Lang & 
Secic 2006), are required to ensure studies have sufficient power to show 
statistical significance. 
1.4.3.2.2 Study Populations 
Much research into the TPB has investigated university students with 
much less focus on general samples or clinical populations (Armitage & Christian 
2003). The use of the T? B in drug and alcohol using behaviours, particularly, is 
done predominantly with college/university students as study participants 
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(Armitage et al 1991; McMillan & Conner 2003; Norman & Conner 2006); an 
easy-to-access population that requires none of the ethical considerations of 
clinical samples. The focus on these populations limits the ability of the TPB to 
generalise findings to general populations, as university students tend to represent 
a younger, healthier subsection of society. 
It is acknowledged that within other domains, i. e., not drug or alcohol use, 
that the TPB has been applied to general and clinical populations; for example, 
Christian and Armitage (2002) examined homeless populations, O'Connor, 
Armitage and Gray (2006) parasuicide patients and Armitage (2005) gym 
attendees. If behaviour change interventions are to be designed as a result of TPB 
predictors of health behaviour then the samples need to be representative of those 
in which the interventions would ultimately be focused on. 
1.4.4 Summary of Findings 
Only two models were found that had been applied to drug using 
populations, the TTM and the TPB. Both have their limitations the TTM in that it 
has wide variability in its measurements of constructs and its lack of predictive 
validity. The TPB in its lack of objective measures of behaviour, short follow-up 
periods and the use of student populations to assess drug behaviour. 
Although the TPB has its limitations it may be more useful as a predictor 
of heroin intention and behaviour than the TTM, as this is more a descriptive 
stage of change model than a predictive model. Thus the TPB could be applied as 
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a framework for predicting heroin use during drug treatment but consideration of 
the limitations within the TPBs applicability need to be addressed. 
1.5 Broad Aims of the Thesis 
The reduction in use of heroin and the subsequent importance of access to 
drug treatment is a high priority. Identification of predictors of continued drug 
use has a central role to play in the identification of those at most risk of relapse 
or treatment drop out altogether. To date, no research has applied a 
psychological framework to the process of drug treatment to predict future heroin 
use and the TPB may be a suitable model. 
The broad aim of the thesis is therefore to assess the efficacy of the TPB 
as a predictor of intentions and behaviour in a population of heroin users. The 
thesis can be broadly divided into three further sections: Firstly, given the TPB 
has not been applied in this area, a qualitative exploratory study will be 
undertaken to examine whether the TPB will be suitable for use in this population 
(Chapter 2), empirical applications of the TPB will then follow (Chapters 3 and 
4), concluding with a summary and future directions (Chapter 5). 
In an attempt to overcome the limitations of the TPB, this thesis will apply 
the TPB to a clinical population of heroin users to examine predictors of treatment 
attendance and heroin use intentions and behaviour during drug treatment; the 
studies will use both objective and subjective measures of behaviour and employ 
a longitudinal design, with a follow-up period of six-months, to assess the 
predictive validity of the TPB over time. In addition it will consider clinical 
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variables, as highlighted in Chapter One, which might contribute to the predictive 
ability of the model, 
1.6 The Next Step 
The following chapter is a qualitative study intended to explore whether 
the TPB would be an appropriate framework for predicting behaviour in this 
population. The main objective is to investigate whether individuals with a heroin 
dependency can think about stopping heroin use in relation to TPB constructs and 
to identify whether any of the predictors already discussed within this Chapter, 








Chapter 2- Beliefs About Stopping Heroin Use in a Population of 
Dependant Heroin Users Attending for Drug Treatment. 
2.1 Introduction 
Whilst treatment is deemed an effective way of reducing illicit drug use 
many studies report the mediating effects of the treatment in question, for 
example methadone, rather than considering the psychological variables of the 
individual in the prediction of ongoing drug use during treatment. Chapter One 
discussed the predictors of continued heroin use, for example peer influence, 
heavy pre-treatment drug use, treatment history and the use of crack-cocaine, 
which have been highlighted from treatment outcomes studies. The limitations of 
the research discussed in Chapter One are that the studies have not been 
conducted from a psychological perspective nor have they utilized a theoretical 
framework to explain the findings. The subjective responses from heroin users on 
their reasons for continued heroin use during treatment is also not explored in 
many studies on treatment outcome. 
The theory of planned behaviour (TPB; Ajzen 1991) is a motivational 
model that has been successfully applied to the prediction of various health 
behaviours, including illicit drug use. This Chapter will examine previous 
qualitative research to identify whether the subjective reasons given by heroin 
users for heroin use fit into the theoretical framework of the theory of planned 
behaviour. This will be followed by qualitative interviews with heroin users to 
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examine whether they think about their drug use in terms that would make the 
theory of planned behaviour applicable in this domain. 
2.1.2 Construct Beliefs in the Theory of Planned Behaviour 
According to the theory of planned behaviour action is guided by three 
kinds of consideration: beliefs about the likely outcomes of the behaviour and the 
evaluation of these (behavioural beliefs), beliefs about the normative expectations 
of others and the motivation to comply with these expectations (normative 
beliefs), and beliefs about the presence of factors that may facilitate or impede 
performance of the behaviour and the perceived power of these factors (control 
beliefs) (Ajzen 1991). These beliefs are important as they provide valuable 
information concerning thoughts and feelings towards a particular behaviour. 
Thus to understand the psychosocial and cognitive determinants of stopping drug 
use it is important to understand which underlying beliefs most strongly determine 
attitude, subjective norm and perceived behavioural control. Previous research 
has examined heroin users' reasons for continued drug use during drug treatment. 
2.1.3 Subjective Need for Treatment and Treatment Outcomes 
Powell et al (1993), as part of a larger study investigating relapse risk, 
interviewed heroin users attending for treatment and who continued to use heroin 
(n--28), to examine details of drug use to enable explomtion of predictor variables. 
Narrative interviews were coded with seven themes emerging as risk indicators; 
negative mood state (n--19), indirect social pressure (presence of other drug users 
in absence of immediate drug availability, n=l 1), direct social pressure (drugs 
made explicitly available, n=6), interpersonal conflict (n=4), environmental 
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factors (presence in an area associated with drugs, n=4), physical discomfort 
(n--2), and the use of other substances (n--I). 
A later study by Best et al (1999) interviewed 109 heroin users attending 
for methadone treatment to examine reasons for heroin use over the previous 90 
days. 70% of participants had used heroin in the previous 90 days with 22% 
(n--24) reporting daily heroin use, on top of a current methadone prescription and 
48% using occasionally9. Three main categories for ongoing heroin use were 
offered; to stop withdrawals, for pleasure and availabilitylo. The most common 
reason given by daily users was to stop withdrawal (92%), followed by for 
pleasure (50%). Occasional users used for pleasure (68%) and to stop 
withdrawals (64%) and were more likely to use because it was available; 20% 
compared to 4% of daily heroin users. 
Shen, McLellan and Merrill (2000) considered participants' perceived 
need for treatment and the impact that may have on treatment outcomes. They 
suggest that treatment is only important for those who feel ready or at least 
somewhat motivated to receive it. Subsequently 'treatment ready' was determined 
by recognition of higher numbers of reported problems associated with current 
drug use' 1 and those who did not perceive any problems relating to their drug use 
were more likely to see treatment as unimportant. Thus they concluded that 
9 Occasional use defined as those not using on a daily basis; between 1-60 days in the previous go. 
10 Categories identified from a previous pilot study 
11 Measured by the use of the Addiction severity index used for the evaluation of patient 
functioning in seven areas: drug use, medical status, employment, psychiatric status, family/social 
relationships and legal status. 
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motivation, determined by recognition of recent problems, made a substantial 
difference in treatment outcome and a good predictor of change. 
2.1.4 Associations Between Subjective Beliefs and TPB Constructs 
The self-reported outcomes of these studies, that explore the reasons for 
continued drug use during treatment, are similar to the belief constructs found 
within the in the TPB; yet, again, studies have not used a theoretical framework to 
base their findings on. 
2.1.4.1 Behavioural Beliefs 
Numerous self-reported outcomes can be put into the context of a 
behavioural belief measure. For example, Powell et al (1993) reported 'negative 
mood state' as a barrier to stopping drug use; hence, the more negative mood state 
the more likely it is you'll use drugs especially if by using drugs the mood state 
improves thus positive reinforcement for ongoing drug use. Also, 'physical 
discomfort', the more physically uncomfortable you become the more likely it is 
you'll use drugs if you believe the physical problems will diminish as a result. 
Best et al (1999) also reports physical withdrawals and also 'pleasure'; thus the 
more pleasure you get from taking drugs the more positive an outcome you will 
perceive and the more likely you will be to use drugs again. Experiencing more 
drug related problems, as reported by Shen, McLellan and Merrill (2000), the 
more likely to you are to view treatment as important and subsequently want to 
stop using drugs. Conversely the less you perceive drug related problems the less 
likely you are to feel ready to stop and more likely to continue using. 
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2.1.4.2 Normative Beliefs 
Examples of normative beliefs constructs derived from subjective reports 
of heroin users are also are reported by Powell et al (1999). Experiencing direct 
social pressure, drugs being immediately available, indirect social pressure and 
association with drug users but in the absence of drugs, increases the chance that 
you are more likely to use drugs in those situations, thus complying with the 
expectation of doing what other people think that you should do. 
2.1.4.3 Control Bcliefs 
Best et al (1999) and Powell et al (1993), cited environmental factors 
(presence in a known drug using area) and drug availability as risk factors that 
could facilitate ftu-ther drug use, which fits with the construct of control, whereby 
the more drugs that are available the less perceived control you feel over using. 
Powell et al (1993) also included reported the use of other substances as a 
predictor of further drug use hence the more combinations of drugs that are used 
the less control you might feel that you have over future drug use. 
The present study is interested in the utilization of the TPB in the 
prediction of heroin use in a population of heroin users attending for treatment. 
Previous research, although not based on specific theoretical frameworks, may 
provide some grounding from which to support the application of the TPB. The 
barriers to stopping drug use during treatment, discussed in the previous sections, 
do appear to relate to the concepts of control, normative and behavioural beliefs; 
for example, not feeling ready to stop, association with others drug users, access 
to drugs, withdrawal features and en oyment, though are not described within that j 
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context. This suggests that the TPB may be useful as predictor of heroin use 
behaviour if heroin users are firstly able to identify beliefs relating to stopping 
drug use within the contextual framework of the TPB. 
As no previous TPB research has been applied to this population, and 
before any empirical application of the TPB to this population is carried out, a 
qualitative study will firstly be undertaken to investigate whether beliefs about 
heroin use can be identified that fit within the behavioural, normative and control 
belief constructs of the TPB. 
2.1.3 Aims 
The aims of this Chapter are threefold; first to investigate whether 
dependant heroin users are able to discuss their thoughts and feelings in terms of 
stopping using drugs, second to examine whether they fit within the framework 
and constructs underlying the TPB and third to explore whether the barriers and 
facilitators of heroin use are associated with drug treatment or congruent with the 
predictors of heroin use discussed within Chapter One and Section 2.1.3. 
2.2 Method 
2.2.1 Participants 
Participants were recruited from statutory specialist drug services in 
Sheffield and were attending for treatment of opiate dependency on a voluntary 
basis. An opportunistic sample was used based on those individuals that attended 
for an appointment on the day the researcher was able to attend the substance 
misuse service. Participants were excluded if they had concurrent alcohol 
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dependency, severe mental health problems, were entering treatment as part of a 
court order, pregnant, homeless or non-English speaking (no resource was made 
available for interpreters). The rationale for this being that they would then be 
representative of future participants as matched exclusion criteria applies. No 
incentives were given for participation in the study. This study was approved by 
the North Sheffield Research Ethics Committee. 
Twenty-three treatment appointments were attended at the substance 
misuse service that day all of which, following screening by clinical staff, were 
deemed as being eligible for inclusion in the study. From the twenty three heroin 
users that attended their appointment seven (30%) agreed to participate in the 
study; two female and five males, the mean age being 27.4 (SD 3.5) and the mean 
number of previous times in treatment was 2.5 (SD 1.6). No information is 
available on the individuals that chose not to participate, as the details were not 
passed forward from clinical staff. 
2.2.2 Procedure 
Participants were identified by attendance at the substance misuse service 
for their appointment with a clinical nurse specialist. Participation in the research 
was initially broached by the clinician and brief information given regarding the 
interviews and intended duration. If in agreement, the participant was introduced 
to the interviewer at that time and consent gained to take part. 
Structured interviews were undertaken, consisting of open-ended questions, 
which took approximately 15-25 minutes. The questions in the interview schedule 
48 
are shown in Table 2.1 and were based on those recommended by Sutton et al 
(2003), for eliciting belief constructs within the TPB. Answers to the questions 
were followed by the prompt 'anything elseT until the participant had nothing 
else to add. The interviews were tape recorded and transcribed. Content analysis, 
a data reduction technique for compressing many words of text into an efficient 
number of categories that represent similar meanings (Weber 1990), was 
undertaken to develop the coding frames for each question. 
2.3 Results 
The number of beliefs elicited ranged from three for the 'disapprove' 
question to 12 for the 'advantages' and 'easy' question. All participants gave at 
least one response (i. e., one belief) to each question and all ended each question 
with either 'no nothing else', 'can't think of anything else' or 'no' to the 
additional prompt 'anything else? '; hence this response been removed from the 
analysis. All participants gave appropriate answers without the need for re- 
phrasing of the questions, which suggests an understanding of what was being 
asked of them. 
Table 2.1: Open-Ended Questions Used in the Study 
1. What would be the advantages of you stopping using heroin in the future? 
2. What would be the disadvantages of you stopping using heroin in the 
future? 
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3. Are there any groups or people who would approve of you stopping using 
heroin in the future? 
4. Are there any groups or people who would disapprove of you stopping 
using heroin in the future? 
5. What do you think would make it difficult for you to stop using heroin in 
the future? 
6. What do you think would make it easy for you to stop using heroin in the 
future? 
2.3.1 Behavioural Beliefs 
Table 2.2 shows the II responses elicited for the behavioural beliefs, 
'advantages' question, with five beliefs being elicited by at least 50% of 
participants. All of the participants (n--7) reported an overall non-specific 'getting 
on with life' as the main advantage of stopping using drugs. This was in addition 
to other responses that focused on specific examples of life change like 'going 
back to work or college, five participants reported 'having more money' as being 
important and 'being able to stop the routine of using drugs everyday' was 
another positive behavioural belief reported by five participants. It is interesting 
that health improvements was only reported by 4 participants, as an advantage of 
stopping heroin use, when this is one of that main reasons the Department of 
Health are encouraging heroin users to enter treatment and stop using drugs, 
alongside reducing crime which was reported by 3 participants (Home Office 
2002). 
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The 'disadvantages' question elicited nine behavioural beliefs, as shown 
in Table 2.3. Initially six participants reported 'no disadvantages' to stopping 
using drugs, until prompted, and even with prompting only a further one belief 
was elicited from the majority of participants (n--5); the belief being that previous 
psychological problems, including 'stress' and 'anxiety' would re-occur. Other 
negative salient behavioural. beliefs included 'social isolation' elicited by two 
participants as they would have to disassociate from drug using peers and 
'difficult to find work' as two participants reported having had no experience or 
skills. 
Table 2.2: Number of Reported Behavioural Beliefs -'Advantages' Question 
Category n=7 
Getting on with life (non-specific) 7 
Stop routine of using 5 
Get back to college/work 5 
Have more money 5 
Health improvements 4 
Feel accepted/reduce stigma 3 
No further crime/illegal activity 3 
Being able to get away/holidays 2 
Not seeing other users 
More contact with family/friends 
No further contact with clinic 
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Table 2.3: Number of Reported Behavioural Beliefs - 'Disadvantages' 
Question 
Category n=7 
No disadvantages 6 
Re-occurrcnce of problems (psychological) 5 
Change of lifestyle 2 
Social isolation 2 
Difficult to find work/no skills 2 
Substitute other drugs 
Get bored 
Find it hard to cope (general) 
Learning to deal with emotions 
23.2 Normative Beliefs 
Table 2.4 reports the number of normative beliefs elicited from the 
'approve' and 'disapprove' questions. All participants reported 'family' as the 
first elicited response to the 'approve' with a total of seven beliefs being elicited 
in total. 'Friends' was a salient category with participants also clarifying they 
were referring to 'non drug using fiiends' specifically. Other categories included 
'health professionals' and 'police' or 'probation staff . 
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A substantial proportion of the participants did not respond with any 
salient normative beliefs to the 'disapprove' question by stating 'nobody'. Of the 
participants who did respond drug associations, in particular 'drug dealers' and 
'other drug users', were elicited as the two referents that would disapprove of 
them stopping using drugs. 
Given the assumption that participants are likely to list referents with 
which they are motivated to comply, the normative beliefs elicited suggest that 
participants had more positive subjective norms when thinking about stopping 
using drugs. 
Table 2.4: Number of Reported Normative Beliefs -'Approve' and 
'Disapprove' Questions. 
Approve n--7 Disapprove n--7 
Family 7 
Friends (non drug users) 6 
Doctors/health professionals 3 
Probation/Police 3 
Everybody 3 
Work colleagues 2 
Society I 
Drug dealer 
Other drug users 3 
Nobody 3 
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233 Control Beliefs 
The 'difficult' question resulted in ten categories of salient control beliefs 
(see Table 2.5) with three categories, 'low motivation', 'withdrawal symptoms' 
and 'craving' elicited by four of participants, two categories 'having money' and 
faccess to drugs' by three of participants, two stated that getting 'no help or 
support' would make stopping drugs difficult, with four further categories elicited 
from individual participants. 
Table 2.6 shows the results of the 'easy' question with 
'medication/treatment' (n7-6), 'support from family' (n--5) and 'support from 
professionals' (n--5) being the most common elicited control beliefs. A total of 10 
salient beliefs were categorised including 'having no contact with other users' 
(n=3), 'having something to do (n--2) and having a 'positive attitude' (n--2). 
Similar numbers of control beliefs were elicited from both questions with 
some beliefs simply being the obverse of each other, for example 'easy'= 
'support/treatment' and 'difficult' = 'no support/no treatment', easy= 'no 
withdrawal symptoms' = 'withdrawal symptoms', 'easy'= 'no contact with other 
drug users' and 'difficult' = 'contact with drug users'. 
The control beliefs elicited from these interviews support earlier subjective 
predictors of continued heroin use gathered from previous qualitative interviews 
discussed in Section 2.2.3, i. e. low motivation, withdrawal symptoms and contact 
with other drug users. Drug treatment and professional support is also highly 
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reported as something that would help to facilitate stopping heroin use, which 
again supports the notion that drug treatment may be important. 
Table 2.5: Number of Reported Control Beliefs - 'Difficult' Question 
Category n=7 
Motivation (low) 4 
Withdrawal symptoms 4 
Craving/Habit 4 
Having money in my pocket 3 
Access to drugslavailability 3 
Support/treatment 2 
Stressful situations (non specific) I 
Anxiety I 
Association with other users I 
Enjoyment I 
2.4 Discussion 
The aims of this Chapter were to investigate whether heroin users are able 
to discuss their thoughts and feelings in terms of stopping using heroin, to 
examine whether they fit within the TPB framework, and to explore whether the 
barriers and facilitators of heroin use are associated with drug treatment or the 
predictors of discussed within Chapter One and Section 2.2.2 of this Chapter. 
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Table 2.6: Number of Reported Control Beliefs - 'Easy' Question 
Category n--7 
Medication/treatment 
Support - professional 5 
Support -family 5 
No contact with other drug users 3 
Employment/education/something to do 2 
Positive attitude 2 
Drug awareness/education 
No withdrawal symptoms I 
Prison 
Receiving positive feedback I 
2.4.1 Summary 
Heroin users are able to discuss and identify their beliefs about stopping 
using drugs in the future during an interview designed to identify factors 
associated with behavioural, normative and control beliefs. Drug treatment and 
receiving support from professionals was elicited as a salient facilitating factor 
(control beliefs) in stopping drug use. Low motivation, withdrawal symptoms, and 
association with drug using peers, were also identified beliefs that support earlier 
research undertaken in this area. These results suggest that the TPB would be a 
useftd framework in which to examine the prediction of heroin use intention and 
behaviour during drug treatment. 
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2.4.2. Facilitating Factors Associated with Stopping Drug Use 
Control beliefs are held to be the barriers and facilitating factors, which 
underlie perceived behavioural control, a determinant of intention, but which can 
also have a direct impact on behaviour and influence behaviour change (Ajzen 
1991) 
Chapter One discussed the importance of drug treatment in enabling 
heroin users to stop using drugs (NTA 2006), by enabling the reduction of 
associated risks, for example, crime, and improving health and lifestyle outcomes 
(Home Office 2002a). The most commonly reported control belief was access to 
drug treatment and medication, thus this supports the suggestions discussed in 
Chapter One (Section 1.1.4) that drug treatment is an important factor for heroin 
users wanting to stop using drugs. Having professional support was the second 
most common facilitating factor in stopping drug use, which also correlates with 
positive normative influences of health professionals. Whilst national strategies 
are being delivered to engage drug users into treatment, it would appear that drug 
users also view this as a facilitating factor in stopping future drug use. 
In terms of behavioural. beliefs being able to 'get on with life' was the 
belief elicited by all participants, 'stopping the routine of using' is another 
advantage suggesting that heroin use becomes habitual and central to life during 
the time you are using. Heroin users have suggested many positive factors that 
are associated with stopping drug use; with a high percentage initially stating that 
there were no disadvantages to stopping. However the use of prompts during the 
interview enabled negative beliefs and barriers to be identified. 
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2.4.3 Barriers Associated with Stopping Drug Use 
A concern about reoccurrence of psychological problems was the most 
common negative belief elicited from the interviews. One of the side effects of 
heroin is the ability to suppress emotional states and allow a sense of 'escapism' 
(Department of Health 2001); hence heroin use becomes the primary coping 
mechanism. The effects of mood state on continued drug use was raised in the 
study by Powell et al (1993), though Brewer et al (1998) did not associate 
psychiatric morbidity with drug use outcomes. This area is perhaps one area that 
requires further exploration as heroin users are stating this as a problem yet 
treatment studies tend not to measure this; in the Brewer et al (1998) meta- 
analysis only 17% of studies reported the effects of mental health problems. 
Having low motivation to stop using drugs, and coping with cravings or 
the habit formation of using heroin were also highly rated as barriers along with 
experiencing physical withdrawal symptoms, this supports the previous self- 
reported barriers to stopping drug use discussed in Section 2.2.3. The negative 
effects of heroin use, withdrawal symptoms, are identified as one of the most 
common control beliefs and as a predictor of continued heroin use during 
treatment (Powell et al 1993). 
Having contact with other drug users and the potential unsupportive 
influence of drug users and drug dealers might also make it difficult to comply 
with treatment if this is also associated with drug availability (Best et al 1999). 
Chapter One reported peer influence as a strong influence on ongoing drug use 
behaviours (Schroeder et al 2001, Termorshuizen et al 2005). The need for non- 
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engagement with drug using peers seems important in stopping drug use, yet 
social isolation, as a result of moving away from a drug using peer group, was 
also identified by two participants as one of the disadvantages of stopping using 
drugs, which may bring with it another set of problems with which to cope. 
Overall, the fmdings support previous research that has examined heroin 
users self-reported barriers to continued drug use. It has also highlighted the 
importance of drug treatment and the subsequent support from health 
professionals as a facilitating factor in stopping future drug use. 
2.4.4 Study Limitations 
The study had only a small sample size (n=7), and although the 
participants were all heroin users, as was the target population, this may not be 
totally representative of all heroin users. The heroin users in this study were all 
attending for treatment and thus may already be thinking about positive and 
negative associations of stopping, this may differ from heroin users that do not 
want treatment or want to stop using drugs. Nevertheless, heroin users entering 
treatment was the target population and by utilising interviews rather than 
questionnaires the data was rich with a high number of beliefs elicited and the 
information gained supported the predictors of continued heroin use, gathered 
from heroin users during treatment, detailed in Section 2.1.3. 
A further limitation in this study was the use of only one researcher for 
transcription of interviews and analysis. Consequently, this could have the 
potential effect of introducing bias and poor internal consistency to the resulting 
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coding frames due to a lack of inter-rater reliability. This limitation should be 
recognised when before attempting to generalise the results to heroin user 
populations. Consistency could have been improved by introducing a second 
reviewer, however, this limitation was imposed on the study due to the restraints 
on available resources. 
2.4.5 Conclusion 
Findings indicate that heroin users can identify a variety of positive and 
negative beliefs about stopping using heroin based on a theory of planned 
behaviour framework. Drug treatment was identified as a facilitating factor in 
stopping heroin use and as such provides the basis in which to empirically apply 
the TPB to heroin use behaviour. 
The structure of the interview, in enabling underlying beliefs about 
stopping using heroin to be identified, also has the potential to be used as a 
clinical intervention during drug treatment Heroin users are able to specifically 
state which salient factors are important in the facilitation of behaviour change 
and thus intervention targeted at specific beliefs. Therefore, the present study 
shows that the TPB might be usefully applied as a framework for predicting 
heroin use in heroin users accessing drug treatment. Further, these underlying 
constructs may also provide a useful tool in clinical treatment settings. 
2.5 Summary 
The findings of the present chapter show that TPB might be usefully 
applied in this population and supports the discussion raised in Chapter One that 
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drug treatment and subsequent support from health professional is an important 
factor in stopping heroin use. Results also support the findings from previous 
self-reported barriers to ongoing drug use (see Section 2.1.3), including 
association with drug using peers, physical withdrawal states, drug availability 
and motivation. It has, however, not generally identified specific predictors of 
continued heroin use during treatment but has identified important beliefs that 
could be further examined during clinical appointments with treatment services. 
2.5.1 Next Steps 
One of the key facilitating factors identified by heroin users for stopping 
heroin use was drug treatment and accessing help from professionals. For heroin 
users to get the most out of treatment they need to feel this has benefits for them 
and that they are motivated to attend (Shen, McLellan & Merrill 2000). We will 
therefore start the empirical Chapters by using the TPB to predict attendance for 
drug treatment before leading onto the application of the TPB in the prediction of 
heroin use during treatment. 
The following chapter will assess the extent to which the TPB can predict 
intention to 'attend appointments at clinic' and actual attendance (behaviour), 
over a period of six-months, in a clinical population of heroin users attending a 




Chapter 3 -Predicting Attendance for Drug Treatment: 
Application of The Theory of Planned Behaviour. 
3.1 Introduction 
The aim of this study is to examine the determinants associated with attendance at 
drug treatment services. The beliefs elicited, from heroin users, in Chapter 2 
suggest that receiving professional support and subsequent medical treatment is 
important for heroin users wanting to stop drug use. 
3.1.1. Attendance in Drug Treatment 
Engaging drug users in treatments,, such as methadone or buprenorphine, 
has been shown to offer positive outcomes in terms of reductions in drug use, 
injecting behaviours, and improved social and psychological functioning (Barnett, 
Rodgers and Bloch 2001, Mattick et al 2003). For drug treatment programmes to 
be effective drug users must attend and sustain regular contact with their clinic 
appointments. Treatment outcomes for patients receiving less than 90 days in 
treatment are not significantly different from those receiving no treatment, an 
indication that 90 days is the minimum time for treatment to be effective (Booth, 
Crowley & Zhang 1996). The National Treatment Agency (NTA) currently set 
substance misuse services targets to ensure individuals with drug problems are 
retained in treatment for a minimum of 12 weeks. Treatment data including 
retention rates and unplanned discharges (treatment drop out) is currently 
collected as part of ensuring the NTA treatments targets are being achieved. 
National data reported for 31/03/07 states that 66% of drug users were retained in 
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treatment over a 12-week period (NTA 2007a); thus 34% did not achieve the 
recommended minimum time for treatment effectiveness to be achieved. 
3.1.2 Treatment Outcome Studies 
Predictors of poor treatment outcome have been highlighted in Chapter 
One; association with other drug users, previous treatment attempts, heavy pre- 
treatment heroin use, frequent crack use and drug users that inject, are consist but 
weak predictors of treatment outcomes across studies (Brewer et al 1998). In 
general studies of treatment outcomes, for example methadone and buprenorphine 
treatment, the focus is on treatment effectiveness for improving pre-treatment 
variables rather than on the characteristics of those participants that have poor 
outcomes. 
As an example, Gerra et al (2004) evaluated the patient/treatment variables 
influencing retention rates in methadone and buprenorphine treatment. They 
concluded by reporting both treatments to be as effective as each other in 
retaining patients over the total 12-week study period (62% vs 59%, p<. 05) but 
that methadone retained more patients in the initial four weeks of treatment than 
buprenorphine (78% vs 67%, p<. 05). Higher doses of treatment were influential 
in retaining methadone patients but dosing was not significant for buprenorphine 
patients and patients in methadone treatment were more likely to use illicit opiates 
than those in buprenorphine treatment (32% vs 25%, p<. 05). There was little 
discussion relating to patient variables, apart from reporting that patients who 
completed buprenorphine treatment were more likely to be depressed than those 
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that dropped out, thus suggesting patient variables are of secondary importance to 
treatment variables. 
Treatment outcomes studies rarely report or suggest the pre-treatment 
variables that are associated with ongoing drug use during treatment. The 
exceptions are those that focus on particular risk factors rather than treatment 
outcomes per se, for example, Moos, Nichol and Moos (2002) examined risk 
factors during treatment, Termorshuizen et al (2005) predictors of relapse, 
Schroeder et al (2001) social predictors of illicit drug use and Williamson et al 
(2007) examined the use of cocaine on treatment outcomes. If treatment studies 
focus on positive outcomes associated with treatment and neglect reporting 
important information such as predictors of poor outcomes it makes it difficult to 
focus intervention at those most likely to continue using drugs during treatment or 
those who risk treatment drop out altogether. 
3.1.3 Theory of Planned Behaviour 
The focus of interest in this study concerns which variables are likely to 
predict actual attendance for drug treatment, taking into account the variables 
discussed in Chapter One which may be predictive of treatment drop out, for 
example, ongoing drug use, drug using associates and previous treatment 
episodes. The theory of planned behaviour (Ajzen 1991) will be used as a 
theoretical framework for the study. The theory of planned behaviour (TPB) 
states that behaviour is predominantly guided by intentions and that behavioural 
intention, in this case, to attend drug treatment appointments can be determined 
by three underlying factors; attitude, subjective norm and perceived behavioural 
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control. Thus a drug user is more likely to intend to attend their appointments if 
they have a positive feeling about it, perceive a social pressure to attend and if 
they believe they will be successful in attending. (see Chapter One for full details 
on the TPB). 
The TPB has been applied in numerous studies to predict various 
behaviours (see Conner & Armitage 1998, Armitage & Conner 2001). In general 
these reviews support the idea that intentions can be explained with high levels of 
variance accounted for by attitudes, subjective norms and perceived behavioural 
control. The prediction of actual behaviour is however more difficult with past 
behaviour often the best Predictor of future behaviour over and above any of the 
TPB determinants (Drossaert, Boer & Seydal 2003, Ouellette & Wood 1998). 
3.1.4 Attendance Studies 
As previous studies of drug treatment attendance are unavailable it is 
perhaps reasonable to examine evidence from other studies that have used the 
TPB as a predictor of attendance, albeit in different populations, as a basis for the 
present study, for example, attending screening appointments for breast cancer 
(Rutter 2000, Drossaert, Boer & Seydel 2003) and Downs Syndrome (Michie et al 
2004). Michie et al (2004) asked 1499 women about their intention to attend for 
Downs syndrome screening at a future appointment as either part of a routine 
hospital appointment or as a separate hospital appointment for the purposes of the 
test only. In the routine and separate appointment groups the TPB was able to 
predict intention to attend V2 =34, p=<. 01 and R2= . 69, p=<. O I respectively) 
with attitude the strongest independent predictor. Subjective norm and perceived 
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control were also significantly predictive of intention, though subjective norm was 
only significant when that related to family and friends rather than the perceived 
pressure from health professionals. Intention was the single independent predictor 
of screening uptake in both groups (Michie et al 2004). 
Drossaert, Boer and Seydal (2003) added past behaviour as a predictor of 
future behaviour when looking at attendance for breast cancer screening. 
Following an initial scheduled appointment, for breast cancer screening, women 
were invited to complete questionnaires regarding their attendance at future 
screening appointments. They found that intention to participate in two future 
rounds of screening was significantly predicted by the TPB variables (R 2= . 49, p 
< . 01), attitude being the strongest predictor. Attendance at 
baseline was 
predictive of attendance at the first follow up appointment, as was intention; and 
attendance for the first follow up appointment was the strongest predictor of 
attendance at the second follow up appointment (R 2=0.32, p<. 01). Inthisstudy 
49% of the variance in intention to attend could be explained by the TPB 
variables whereas TPB variables could only explain 15% and 18% variance in 
actual behaviour at rounds two and three respectively with past behaviour being 
the strongest predictor. This supports the previous results found by Ruttcr (2000), 
in which attitude, subjective norm and perceived control were all independent 
significant predictors of intention to attend future screening appointments 
accounting for 29% of the variance. Past attendance was the only significant 
predictor of re-attcndance some 3-years later (p <01). 
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Most closely related to the present population being studied, Christian and 
Armitage (2002) used the TPB to investigate homeless people's participation in 
outreach service programmes. One hundred and four homeless people were 
interviewed with the aim of assessing the utility of the TPB in predicting intention 
and future participation in future outreach programmes. In this study attitude 
emerged as the single significant predictor of behavioural intention explaining 
46% of the variance with behavioural intention (, 6 = 1.84, p< .0 1) and subjective 
norm (fl = 1.72, p< . 01) being significant predictors of participation in service 
provision with past behaviour not significant in predicting future participation. 
Attendance studies support the theory of planned behaviour to predict 
intention though the ability of the TPB to Predict actual behaviour in this context 
is not strong, with past behaviour being the strongest predictor of future 
attendance behaviour. In drug misuse research, as mentioned in Chapter One, 
previous treatment experiences may have an inverse effect on future behaviour 
with poor outcomes among treatment-cxperienced patients, and less compliance 
with treatment than those entering treatment for the first time (Brewer ct al 1998, 
Hser et al 1999, Darke et al 2005). Previous TPB research has incorporated prior 
behaviour as a proximal determinant of intention and behaviour (Drossaert, Bocr 
& Seydal 2003, Christian & Armitage 2002). Conner and Armitage (1998) report 
that the addition of past behaviour to the TPB variables explains, on average, an 
additional 7% of the variance in intention and 13% in behaviour. As Chapter One 
also suggests past behaviour (previous treatment) as a predictor of treatment 
outcomes this study will include previous treatment episodes as an indication of 
past behaviour. 
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3.1.5 Rationale for the Present Study 
The present study will use the TPB as a framework to examine predictors 
of behavioural intention and attendance. The participants will be a clinical 
population of heroin users that are attending substance misuse services for drug 
treatment. 
A limitation of previous T? B studies has been the use of self-reported 
behaviour data, which are vulnerable to a number of biases, yet Elliott, Armitage 
and Baughan (2007) have reported that the TPB is able to predict and account for 
high levels of variance (31%-39%) in actual behaviour; hence, testing the 
predictive validity of the TPB with objective measures of behaviour is important. 
This study will use objective measures of actual attendance that will be collected 
from clinical records and information systems held at the drug treatment service. 
A further limitation of previous TPB studies is the lack of follow- up, 
which has been discussed in detail in Chapter One, which may be limiting the 
ability of the TPB to predict intention and behaviour over time. This study will 
attempt to overcome this by collecting follow up data over a period of six-months, 
the time suggested within the TTM (Prochaska & DiClemente 1986) for the 
maintenance of behaviour change. 
Additional variables have been included in the study that have been 
identified from Chapter One as being predictors of ongoing drug use and 
treatment drop out; pre-treatment drug use (heroin and crack), association with 
drug using peers (social relationships) and previous treatment (past behaviour). 
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Thus it is of interest to determine the relative importance of the social cognition 
variables when compared to clinical variables. The use of additional variables is 
encouraged by Ajzen (1991) "if it can be shown that they capture a significant 
proportion of the variance in intention and behaviour after the TPB variables have 
been taken into accounf' (p. 199). The addition of clinical predictors, and past 
behaviour, has been addressed by O'Connor, Armitage and Gray (2006) in their 
study of parasuicide behaviour. Clinical variables, depression, hopelessness and 
anxiety, were included in the final model with depression being significant in 
parasuicide intention, though were not significantly predictive of suicidality, 
beyond the effects of the TPB variables. 
So that the TPB is able to predict continuous behaviours rather than single 
actions, i. e. repeat attendance for clinical appointments, survival analysis 
techniques will be employed to examine predictors of change. Survival analysis 
techniques are able to predict times to a particular event or end-point (Collett 
2003), for example treatment dropout. Traditionally used in medical research to 
predict time to event, i. e. the onset of disease or death, psychology has also started 
to use these techniques to predict changes in behaviour. Elliot, Armitage and 
Baughan (2007) and Armitage (2005) have used these techniques to predict 
driving and exercise behaviour respectively, thus are able to predict which TPB 
variables are associated with behaviour change over time. The use of survival 
analysis techniques is discussed in further detail in Section 3.3.4.6. 
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3.1.6 Aims 
The aims of the present study are as follows: to explore whether attitudes, 
subjective norms and perceived behavioural control are predictors of heroin users 
intention to attend clinical appointments. To test the predictive validity of the 
TPB with regards to objective measures of behaviour and to investigate whether 
the TPB can predict time to treatment dropout. 
It is predicted that the TPB variables would support the predictive validity 
of behavioural intention and that using an objective measure of behaviour would 
ftuther support the validity of the TPB; that TPB variables would explain 
additional variance in behaviour beyond that accounted for by clinical variables 




Participants were recruited from statutory specialist drug services in 
Sheffield and were attending for drug treatment on a voluntary basis. Participants 
were not eligible for inclusion to the study if they were already in prescribed drug 
treatment, were receiving treatment on a coerced basis, for example as part of a 
court mandated treatment order, if they were pregnant, homeless, had severe 
mental health problems or they had concurrent alcohol dependence syndrome. No 
incentives were given for participation in the study and the study was approved by 
the North Sheffield Research Ethics Committee. 
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Following an assessment appointment 138 referrals were made to the 
study, 28 of which were excluded (see Figure 3.1); 18 refused to consent and a 
further 35 12 did not attend to start drug treatment (treatment appointment) 13 , 
leaving a sample of 57 participants that were recruited. The sample consisted of 
15 women (Mean age=35.07 sd=9.55) and 42 men (mean age=31.43 sd 5.605) all 
of whom had been assessed by a clinical nurse specialist, diagnosed as having an 
opiate dependency and were attending the substance misuse service to start drug 
treatment. 
3.2.2 Study Design 
The study was longitudinal in design conducted over a six-month period. 
Initial data were collected at baseline, to coincide with start of drug treatment, 
with a follow-up period of six months. Attendance was monitored over the six- 
month period by accessing data from the substance misuse service on the number 
of appointments offered to each participant and confirming how many 
appointments were attended and how many were not attended. 
12 As the 35 drop outs had not yet consented to the study only names and appointments times are 
available, thus we have little information on these individuals and therefore cannot make 
inferences about why they did not attend for treatment 
13 Following an assessment appointment with a nurse a follow-up appointment is booked with a 
doctor to initiate drug treatment 
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Figure 3.1: Recruitment Process 
Referrals n-- 138 
Excluded n= 28 (20%) 
Court mandated 
treatment n= 10 
Homeless n= 7 
In treatment at 
referral n= 10 
Pregnant n= I 
3.2.3 Procedure 
Refused Consent n-718 (13%) 
Participants n--57 (42%) 
Did not attend for 
treatment appointment 
n7-35 (25%) 
Arrested n= 4 
Dropped out n=31 
Participants were identified by attendance at either of the two Sheffield 
substance misuse services for their initial assessment appointment with a clinical 
nurse specialist, social worker or doctor. Referral forms and inclusion criteria 
posters were left with recruitment sites, in the clinical rooms and reception areas. 
Participation in the research was initially broached by the clinician and brief 
information given regarding the study. Referral forms were completed giving 
information on the participant's name, contact details and date of their treatment 
appointment. 
At the treatment appointment with the doctor, which would usually be the 
appointment given for start of prescribed drug treatment, the participant would be 
given information sheets, informed consent was obtained at this time and 
participants were invited to complete questionnaires to gather baseline data. 
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Interviews were conducted 14 comprising interviewer-led questionnaires (questions 
asked and recorded by interviewer) and self report questionnaires. The interviews 
took approximately 20 minutes to complete depending on the literacy of the 
individuals participating. 
Participants would continue their treatment programme as agreed with 
their treatment service and involvement within the study would have no bearing 
on the treatment they would receive. Follow-up attendance data would be 
collected at six-months. 
If the participant did not attend for the treatment appointment they were 
either contacted directly, if it was felt to be appropriate by the clinician, or 
information was given for subsequent treatment appointments. If no further 
contact had been made or appointments attended within 4 weeks it was assumed 
the individual no longer required drug treatment and were discharged from the 
treatment service". 
The recruitment process relied solely on referral from the recruitment sites 
and hence co-operation of the clinicians working within those services. The 
treatment services did not hold specific assessment clinics with nurses seeing 
patients throughout the week depending on individual diaries, therefore the 
engagement with the clinicians in this process was paramount to recruitment. In 
14 Although the data collected was quantitative, interviews were undertaken due to the nature of 
some of the measures being used, namely the Opiate Treatment Index (see Section 3.3.4.1), it 
gives the participants and researcher chance to ask for clarification and reduces the potential for 
missing data. 
15 The 4-week limit was the time allocated by the treatment service; thus, if no contact was made 
by the individuals within this time frame they would be discharged. 
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an attempt to improve the recruitment rates, treatment services were visited 
regularly, especially at times of low referral numbers, weekly phone calls were 
made to the treatment services to check clinicians' diaries for assessment times 
and to remind clinicians' of the study and refen-al criterion and reminders were 
sent through the post. 
The introduction of court ordered treatment initiatives from the 
Department of Health during the recruitment period significantly reduced the 
numbers of heroin users available for recruitment purposes, as voluntary 
assessment slots were re-allocated for this purpose. 
3.2.4 Measures 
3.2.4.1 Demographic data 
Demographic data included: gender, date of birth, marital and employment 
status, ethnicity, whether they had children living with them, the amount of times 
they had previously been in drug treatment and the number of other drug users 
they currently had regular contact with (reported as social relationships). Data 
were categorical with the exception of age and previous treatment, which 
remained continuous (see Table 3.1 in results Section for categorisation of 
demographic data). 
3.2.4.2 Drug Use 
Drug use behaviour was gathered using the Opiate Treatment Index (OTI) 
( Darke et al 1991, Darke et al. 1992) a validated, structured, interviewer-led 
questionnaire designed to monitor drug treatment outcomes. The OTI consists of 
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six sections; Drug use, HIV risk taking behaviour, social functioning, criminality, 
health and psychological adjustment. Initial questionnaire construction was tested 
on 290 opiate users; see Darke et al (1992; 1991) for full details of the analysis 
undertaken and results. Test-retest and inter-rater reliability methods, with all 
except the drug use section, showed good internal reliability scores. As the drug 
use section covers II different drugs it was not considered appropriate to combine 
the drug use data into a single scale instead the provision of drug use data for each 
category was seen as a reliable means of presenting this section. Validity was 
gained by correlations with a previously validated outcome measure, the 
Addiction Severity Index (McLellan et al 1980), and by obtaining collateral 
information from interviews with participants' partners, medical assessments, 
urine screens and criminal records 16 . The OTI, originally designed in Australia, 
has been replicated for use within the UK by Adelekan et al (1996) with 
comparable results and has more recently been used by Keen et al (2003) to 
examine outcomes of methadone treatment in a UK population. The findings 
suggest that the OTI scales are capable of obtaining accurate self-report 
information. 
The OTI drug scale has eleven drug categories; heroin, other opiates, 
alcohol, cannabis, amphetamines, cocaine, tranquillizers, barbiturates, 
hallucinogens, inhalants and tobacco. Because of the rise in, and harms related to, 
the use of crack-cocaine (crack) within the UK, (Home Offlice 2002b) crack was 
added as an additional variable to the drug use section, making 12 drug categories 
in total from which to collect drug use data. In this study recent drug behaviour is 
16 All correlations with the Addiction Severity Index were significant top <. 05. 
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examined by collecting self-reported information on heroin and crack use only, as 
these are the drugs of interest. 
For each drug class the participant is asked when their three most recent 
days of use occurred and how many times they used, within the last month. The 
interval between days of use is taken as an estimate of frequency of use and the 
number of times they used each day taken as the quantity consumed. The day of 
interview is not recorded, as that does not represent a full day's use. The data 
obtained is then used to get an estimate of recent use by using the following 
formula (Darke et al 1991) 
ql + q2 
Q= 
tl +Q 
Q average use per day 
qI amount used on the last occasion 
q2 amount used on the second last occasion 
tI= interval between last and next to last day of drug use 
Q= interval between second and third days of drug use 
Heroin use, crack use, and social relationships were extremely highly 
correlated; heroin and crack (r =. 99, p< 0.0 1), heroin and social relationships (r = 
. 99, p< 0.01), and crack and social relationships (r = . 98, p< 0.01). Tberefore a 
combined 'Drug Use' scale was used for the purposes of regression analysis. The 
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drug use scale showed good intemal reliability with Cronbach's cc = . 792. This 
reflects previous assumptions made in Chapter One that association with drug 
using peers is predictive of drug use. 
3.2.4.3 Drug Treatment 
Ongoing drug treatment and the length of time in drug treatment for those 
who dropped out, were collected from computer records at the substance misuse 
services. The drug treatments were categorised into either; ongoing treatment or 
dropped out of treatment and length of time in treatment was calculated on weekly 
increments, with the start of treatment taken from the data of baseline data 
collection through to week 26 signifying the end of the study period. 
3.2.4.4 Attendance at Clinic Appointments 
Attendances at subsequent clinical appointments at the substance misuse 
service were collected for the following 6 months by way of computer and 
medical records. Attendance was calculated by dividing the proportion of 
appointments attended by the number of appointments actually offered. As each 
participant had an individual treatment plan, including frequency of attendance, 
proportion was thought to be the best way of measuring attendance to reflect the 
percentage of actual attendance for each participant. 
Appointments attended x 100 = proportion of attendance 
Appointments offered 
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3.2.4.5 Theory of Planned Behaviour Variables 
The theory of planned behaviour predictor variables, relating to attendance 
at clinic appointments, were measured using standard items (Ajzen 1991) on 7- 
point scales. 
The present study uses direct construct measures, to predict intention and 
behaviour, rather than belief based measures and the rationale for this is fourfold. 
Firstly, Armitage & Conner (2001) have provided evidence for the use of the TPB 
in predicting intention and behaviour as a result of direct measures, secondly, no 
previous application of the TPB has been made to heroin users so it may be 
appropriate to start with the direct measures recommended by Ajzen (1991), 
thirdly, to include belief based measures, for example those already identified in 
Chapter Two, would require a much larger sample size which would be beyond 
the resources available for this study and finally using only direct measure will 
reduce the burden to participants literacy. 
3.2.4.5.1 Behavioural Intention 
Behavioural intention was measured on four bipolar (-3 to +3) scales using 
the items: 'I intend to attend all my appointments at clinic definitely do not- 
definitely do, 'I plan to attend all my future appointments at clinic strongly 
disagree-strongly agree, 'I would like to attend all my future appointments at 
clinic definitely do not -definitely do'and 'How likely is it that you will attend all 
your future appointments at clinic very unlikely-very likely' The internal 
reliability of this scale was good (Cronbach's a =. 807). 
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3.2.4.5.2 Attitude 
The attitude measure was assessed with two items asking participants to 
rate on a bi-polar scale (-3 to +3) whether 'Attending all my future appointments 
at clinic would be' good-bag and wise-foolish. The attitude scale had good 
internal reliability (Cronbach's ct =. 829) 
3.2.4.5.3 Subjective Norm 
Subjective norm was described using two unipolar (1-7) rating scales: 
'Most people that are important to me think I should not attend all my future 
appointments at clinic -I should attend all myfuture appointments at clinic, The 
people that I value think I should attend all my future appointments at clinic 
strongly agree- strongly disagree'. The subjective norm scale possessed 
acceptable internal reliability (Cronbach's a =. 673). 
3.2.4.5.4 Perceived Behavioural Control 
Perceived behavioural control was measured by scoring the following 
three items on a 7-point unipolar (I to 7) scale 'For me to attend all my future 
appointments at clinic would be difficult - easy', Uow confident are you that you 
can attend all your future appointments at clinic not very confident-very confident' 
and 'How much do you feel that attending all your future appointments at clinic is 
beyond your control not in control - control'. Cronbach's ot showed that the scale 
possessed good internal reliability (a =. 722). 
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3.2.4.6 Analysis 
The focus of the analysis was to test the power of the theory of planned 
behaviour to predict intention to attend clinic appointments for drug treatment and 
to examine which variables may be predictive of attendance. Pearson's 
correlation coefficient was initially used to explore the strength of association 
between the theory of planned behaviour and the drug using variables, using a 
one-tailed test as is usual in the theory of planned behaviour analysis as there is a 
specific direction to the hypothesis being tested; the higher the behavioural 
intention the greater attendance at clinic appointments. 
Correlations are able to tell us about the association between variables but 
tell us little about the predictive power of variables. Regression analysis fits a 
predictive model to the data and uses that model to predict values in the outcome 
(dependent) variable from a single predictor (independent) variable; multiple 
regression allows several predictors to be included. In this study hierarchical 
multiple regression will be used, as this will enable predictors to be added to the 
model to examine the predictive power of the theory of planned behaviour 
variables and drug using variables in predicting behavioural intention and actual 
behaviour (attendance at clinic appointments) also to explore which predictors 
produced significant improvements in model fit. 
Survival analysis will be conducted to plot time to treatment drop out. 
Survival analysis is concerned with studying time-to-outcome data, for example, 
the time between study entry until the occurrence of a subsequent event or 
outcome, in this case dropping out of treatment. For drug treatment to be 
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effective it is suggested that a minimum retention rate of 90 days is required 
(Booth Crowley & Zhang 1996). 
Data looking at survival times or times to a specific event are generally not 
symmetrically distributed and is therefore not amenable to standard statistical 
procedures (Collett 2003). The main feature of survival analysis is that survival 
times are classed as censored. Censored data occur when the end point of interest 
has not been observed for that individual, for example, individuals lost to follow- 
up where the outcome for that person is unknown. In this study where treatment 
drop out is the event of interest those participants still in treatment at the end of 
the study would be deemed censored as drop out would not have occurred by the 
final round of data collection. 
As an example of survival analysis techniques, Dobkin et al (2002) 
examined treatment drop out with a sample of drug users starting a 6-month 
treatment programme, to examine treatment drop out between two groups of 
patients assessed as having low and high social support. Survival functions for 
both groups were compared results showing higher attrition rate for the low 
support group with mean survival times of 100 days compared to 180 days for the 
group with high social support. For the purposes of this study survival analysis 
will be used in its simplest terms to estimate time to treatment drop out. 
Finally a Cox regression analysis will assess the association between the 
predictor variables and survival rate. A haza d ratio or risk ratio (Exp (0) 
calculates the degree of risk associated with each variable on the effect of an event 
82 
happening, for example, the risk each variable has on treatment drop out. Hazard 
ratios less than one indicate reduced risk and those above one indicate increased 
risk of the event occurring (Lang & Secic 2006). 
3.3 Results 
3.3.1 Participants 
A total of 57 participants were recruited to the study (see Table 3.1) of 
those 74% were male, 26% female, the mean age being 32 years. 51% of 
participants were single, the majority being white (93%), unemployed (67%), and 
having no children (79%). Heroin was the most frequently used opiate at baseline 
(83%) with 37% also using crack-cocaine. Injecting accounted for 28% of the 
route of administration with smoking being the most popular way of using opiates 
(54%). Half of participants reported having no regular associations with other 
drug users (53%) and the mean number of times in treatment was 2.09 (SD 2.33). 
Comparative data was received from the Sheffield Drug and Alcohol 
Action Team 17 to examine whether the present sample was representative of the 
numbers of individuals entering drug treatment within Sheffield. Unfortunately 
only proportionate data was available as raw data is not within the public domain 
hence tests of significance were unable to be conducted. From the information 
available Table 3.1 does show that the study sample is well matched to the 
Sheffield drug using population on age, gender, ethnicity and drug use. The only 
difference being the Sheffield population does have a slightly higher percentage 
17 Acknowledgment is to be given to Bradley Spencer, Data and Information Assistant, of 
Sheffield Drug and Alcohol Action Team for his support in supplying the Sheff ield data. Statistics 
originate from the National Treatment Agency, National Drug Treatment Monitoring System 
(NDTMS) May 2007. 
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of injecting drug users than the study sample. Nevertheless, the present sample is 
broadly representative of people entering drug treatment in Sheffield. 





Mean Age in Years (SD) 32 (6.9) - 
Age 
< 19 0 (0%) (0%) 
20-24 6(11%) (12%) 
25-39 16 (281/6) (24%) 
30-34 13(23%) (27%) 
35-39 14(25%) (19%) 
40-44 6(10%) (10%) 
45+ 2 (3%) (80/0) 
Gender 
Male 42(74%) (73%) 
Female 15(26%) (2 7 */o) 
Marital Status 
Single 29 (51%) - 
Married/Cohabiting 17 (29%) - 
Divorced 1 (2%) - 
Widowed 1 (2%) 
With partner 9 (16%) 
Ethnicity 
White 53 (93%) (89%) 
Mixed Race (2%) 
Black (African/Caribbean) 1 (2%) (5%) 
Asian 3 (5%) (3%) 
Other (1%) 
Employment status 
Unemployed 38(67%) - 
Disabled 7(12%) - 
Full-time 8(14%) - 
Part-time 3 (5%) - 
Self-employed 1 (2%) - 




Opiate Use at Intake 
Heroin 47(83%) (80%) 
Methadone 6(10%) (5%) 
Other opiate 4 (7%) (3%) 
Crack Use at Intake 21 (371/6) -- 
Route of Administration 
Intravenous 16(28%) (3 4 1/6) 







No. Times in Previous Treatment (sd) 2.09 (2.33) 
' Primary opiate use reported for Sheffield (Sheffield drug treatment services also accept referrals 
from non-opiate drug users) 
3.3.2 Predictive Validity of the Theory of Planned Behaviour 
Table 3.2 shows the means, standard deviations and intercorrelations 
among the variables. It can be seen that behavioural intention was correlated with 
perceived behavioural control (r = . 41, p <. 01), attitude (r = . 24, p <. 05) and 
negatively correlated with the number of previous treatment episodes (r = -. 35, p 
<01) suggesting that the more previous times a person has been in treatment the 
less likely their intention to attend future appointments. Attendance, in turn, was 
correlated with perceived behavioural control (r = . 25, p <05) and subjective 
norms (r = .31, p <05), hence the more control you feel you have and the more 
you feel it important to do what others would want you to do the more likely you 
are to go to appointments. Attendance was also correlated drug using variables; 
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the number of other drug users they socialise with (r = . 26, p <05), and heroin use 
(r = . 24, p <05) appears to be a relevant factor in attendance. Perceived 
behavioural control had significant negative associations with the drug variables, 
heroin use (r = -. 5 1, p <0 1), crack use (r = -. 53, p <0 1), and social relationships 
(r = -. 52, p <01), which would suggest that the more drug using behaviour and 
drug relationships you are involved in the less perceived control you have over 
attending future clinic appointments. 
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3.3.3 Determinants of Behavioural Intention 
Hierarchical regression analysis was used to examine the predictors of 
behavioural intention (see Table 3.3). The first step was to examine the theory of 
planned behaviour variables in predicting attendance for drug treatment; step two 
added the 'drug use' items, a combined heroin use, crack use and social 
relationships scale which were predictors of drug use highlighted in Chapter One, 
and finally step 3 added previous treatment (past behaviour) to examine whether 
this is able to predict future behaviour over and above TPB variables (Conner & 
Armitage 1998). 
Step I demonstrates that the theory of planned behaviour variables were 
significant predictors of intention explaining 21% of the variance with perceived 
behavioural control having a significant influence on intentions (P = .39p< .0 1). 
Thus those participants who perceived more control over attending their clinic 
appointments had higher attendance rates. 
Adding the drug using variables in step 2 significantly increases the 
amount of variance explained in intentions from 21% to 31%. Both perceived 
behavioural, control (P = . 60) and 
drug use (P = . 38) had significant beta weights 
showing higher levels of drug using behaviour were associated with a higher 
intention to attend appointments. 
In step 3 of the regression analysis previous drug treatment was added, 
significantly predicted intention (R 2= . 34, F=4.97, df = 1,48, p< . 01), with 
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perceived behavioural. control (P =. 54, p <. 01) and the drug items . 32, p 
. 05) as the main significant influences on intention. 
Table 3.3: Hierarchical Regression Analysis - Predicting Behavioural 
Intention 
Variables R2 zR2 F .6 
Step 1 . 21 . 21 4.53** 
Attitude . 22 
Subjective Norm . 01 
Perceived behavioural control . 39** 
Step 2 . 31 . 10 5.60** 
Attitude . 19 
Subjective Nonn -. 05 
Perceived behavioural control . 60** 
Drug use . 38** 
Step 3 . 34 . 03 4.97** 
Attitude . 17 
Subjective Norm -. 07 
Perceived behavioural control . 54** 
Drug use . 32* 
Previous Treatment -. 08 
* <. 05 
**<. 01 
3.3.4 Determinants of Clinic Attendance 
A second regression analysis was conducted with attendance as the 
dependent variable to examine which variables are predictive of actual behaviour 
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(see Table 3.4). The variables were added in the same order as the previous 
regression analysis, for consistency. The theory of planned behaviour variables, 
behavioural intention, attitude, subjective norm and perceived behavioural 
control, were first included and explained 19% of the variance in attendance. 
Subjective norm was the only variable to be predictive of actual attendance at 
appointments (P = . 29, p< . 05). Thus the more you want to do what others think 
you should do, in this case those that are important to you, the more likely you are 
to attend appointments. 
Step 2 adds drug use, which increases the variance associated with 
attendance (R 2= . 23) though is not itself a significant predictor of actual 
behaviour. The final step in this analysis adds previous treatment. The addition 
of previous treatment as an independent predictor significantly increases 
predictive power of the regression model by improving the variance to 26% (R 2= 
. 26, F=2.68, df = 1,47, p< . 05) but previous treatment does not itself predict 
actual behaviour and attendance. Subjective norm is the strongest independent 
predictor of attendance at treatment appointments (P =. 35, p <. 05). Thisfinding 
is interesting and contrary to prediction as, within the TPB, the effects of 
subjective norm on behaviour should be mediated through intention thus conflicts 
with current theoretical understanding of the determinants of actual behaviour. 
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Table 3.4: Hierarchical Regression Analysis - Predicting Clinic Attendance 
Variables R2 dR2 F J6 
Step 1 . 19 . 19 2.90* 
Behavioural intention . 01 
Attitude -. 24 
Subjective norm . 29* 


































3.3.5 Treatment Drop Out 
The following section will change focus and examine the time to treatment 
drop out and survival rates. 
3.3.5.1 Survival Times to Treatment Drop Out 
Standard survival analysis was used to explore the time taken to drop out 
of drug treatment; operationalised as the time when drug treatment had stopped 
and the participant was not longer attending clinic appointments. The study 
period was over 26 weeks and right-censored data is included within the analysis. 
A Kaplan- Meier curve was computed, which is a step function with jumps at 
observed failure times; the horizontal lines represent the passing of time and the 
vertical lines the proportion of participants that dropped out of treatment (see 
Figure 2). By the end of the study 37/57 (65%) of participants remained in drug 
treatment. The Kaplan-Meier curve shows that there are no significant time 
periods when drop out occurred, with 21 events during the 26-week period and 
the overall mean survival time was 20 weeks. 
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lrotal length of time In treatment (26 vveeks) 
To assess the association between the predictor variables and survival rate 
(treatment drop-out) a Cox regression analysis was calculated. Table 3.5 
highlights that drug use has the greatest effect on treatment drop out with those 
still using drugs 1.8 (Exp (P) = 1.81, p <. 001) times more likely to drop out of 
treatment than those who do not use drugs. Those with a high level of intention to 
attend are more likely to stay intreatment (Exp(P)=. l9, p<. 00l). 
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Table 3.5 Cox's Regression Analysis Showing the Effect of Predictor 
Variables on the Risk of Treatment Drop Out 
Predictor Variables SE Wald p- Exp 95% C1 
)? value (p) 
Behavioural. -1.67 . 50 11.24 . 001 . 19 . 07 to . 50 
Intention 
Attitude - . 08 . 65 . 02 . 903 . 92 . 26 to 3.32 
Subjective norm - . 66 . 66 1.02 . 313 . 52 . 14 to 1.87 
Perceived Control . 06 . 25 . 07 . 798 1.01 . 65 to 1.74 
Drug Use . 60 . 18 
11.40 . 001 1.81 1.30 to 2.55 
Previous treatment - . 18 . 13 2.10 . 835 . 84 . 65 to 1.10 
3.4 Discussion 
3.4.1 Summary of Findings 
The present study provides support for the use of the TPB as a predictor of 
drug treatment attendance intention and actual behaviour over a six-month period. 
Most notably the subjective norm component, which is not generally associated 
with the prediction of behaviour, was the only significant predictor of actual 
behaviour in this context. Drug use (combined clinical variables) was a 
significant predictor of attendance intention along with perceived behavioural 
control. Ongoing drug use had the greatest impact on treatment drop out and those 
with higher levels of intention to attend are more likely to stay in treatment. 
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3.4.2 Efficacy of TPB 
3.4.2.1 Prediction of Intention 
The TPB variables were able to account for a significant amount of 
variance in attendance intention (R 2= . 21) with perceived behavioural control 
being the single independent predictor. This is in contrast to previous attendance 
studies (Drossaert, Boer & Seydal 2003, Mitchie et al 2004, Rutter 2000), which 
report attitude, subjective norm and perceived behavioural control all to be 
significant independent predictors of attendance intention for health related- 
screening. 
The inclusion of the 'drug use' measure" significantly increased the 
amount of variance explained in intentions by 10%. This supports the inference 
made by Shen, McLellan and Merrill (2000) in Chapter Two which suggests that 
the more perceived problems associated with drug use the more motivated you 
might be to access drug treatment and be 'treatment ready', whereas those who 
did not perceive any problems were more likely to see treatment as unimportant. 
Thus they concluded that motivation determined by problem recognition was a 
good predictor of change. This is in contrast to the prediction that TPB variables 
can increase the variance in intention over and above clinical variables, thus 
suggesting drug use variables are of important predictors of attendance intention. 
"' 'drug use' was a combined measure of heroin use, crack use and social relationships 
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3.4.2.2 Prediction of Behaviour 
Unexpectedly, neither intention nor perceived behavioural control were 
significant predictors of behaviour. One consideration for lack of effect of 
perceived behavioural control on behaviour could be due the relatively large 
standard deviation (see Table 3.2) and the significant negative associations 
between perceived behavioural control, heroin use, crack use and social 
relationships. Findings from Rutter (2000) and Drossaert, Boer and Seydel (2003) 
also report intentions, as not being significantly predictive of future attendance 
behaviour, thus intentions and perceived behavioural control it seems are not 
important determinants of attendance behaviour in this population. And whilst 
drug use, a composite measure consisting of pre-treatment drug use and 
association with other drug users, was significant at predicting intention to attend 
for treatment it was not significant in predicting actual attendance. However, 
Cox's regression analysis revealed continuous drug using behaviours during 
treatment increases the risk of treatment drop out and higher levels of intention 
reduces the risk of treatment drop out, which supports studies by Gossop, Duncan 
and Marsden (2003) and Booth, Crawley and Zhang (1996) that suggest drug use 
behaviours, during treatment, are predictive of treatment drop-out (see Section 
1.2.3. ). 
3.4.2.2.1 Subjective Norm in the Prediction of Behaviour 
It was possible to explain 26% of the variance in actual behaviour; 
subjective norm was the single independent predictor of attendance for drug 
treatment. The normative component of the TPB has been reviewed by Armitage 
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and Conner (2001). Whilst subjective norm is argued to be the weakest predictor 
of intention it is suggested this could be due to the number of items used to 
measure this component and if multiple measures of subjective norm are used this 
may provide strong relationship with intention, though the relationship with 
behaviour is typically not reported. It is also worthy of note that very few studies 
even test a direct link between subjective norm and behaviour as this is not a 
relationship defined within the TPB. 
Interestingly, the prediction of behaviour from subjective norm does 
support the results found by Christian and Armitage (2002) where subjective 
norm was significantly predictive of uptake of outreach service for homeless 
individuals. It could be suggested that it is the target populations, in both cases 
vulnerable and hard to access populations, which might put value on perceived 
social pressure and weight their motivation to comply highly. Chapter Two 
identified family, non drug users and health professionals as strong normative 
influences perhaps suggesting that that the impact on behaviour is through a 
strong influence on wanting to do what is expected by a non-drug using society 
and that their actions are driven primarily by subjective norms. 
Attempting to engage drug users with treatment health interventions that 
also incorporates family members or significant others may strengthen the 
likelihood of the behaviour being successful. Kidorf et al (2005) report utilising a 
behavioural intervention 19, to designed encourage opioid-dependent individuals to 
19 The programme comprised a mixture of weekly individual counselling sessions, group counselling and a 
community monitoring support group (that includes the significant other). The level of intensity and 
participation in counselling sessions increases as progress is Wrig made (monitored by urine samples). 
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involved a drug-free family member or friend in their care whilst receiving drug 
treatment, to facilitate the development of a supportive non drug using social 
network. Approximately 78% of participants that participated in the social 
support intervention achieved at least four consecutive weeks of abstinence. 
3.4.3 Past Behaviour 
Past behaviour (previous treatment) had a non-significant relationship with 
both intention and behaviour. This is contradicts the hypothesis that past 
behaviour would predictive of future behaviour that was based on previous 
findings in drug treatment outcome studies, discussed in Chapter One, and the 
attendance studies discussed in Section 3.1.4. Previous attendance for drug 
treatment was identified in Chapter One as a predictor of poor outcomes for future 
treatment (Brewer et al 1998, Darke et al 2005, Hser et al. 1999) and when actual 
behaviour was an added predictor in previous attendance studies (Drossaert, Boer 
& Seydal 2003, Rutter 2000) it was the strongest significant predictive of 
behaviour. However, the results from this study do not support past behaviour as 
being significantly predictive of future behaviour. The lack of significance in past 
behaviour predicting future treatment attendance suggests that attendance 
behaviour in this population is under the influence of other conditions, in this case IT- 
subjective norms. Thus previous treatment experiences, successful or 
unsuccessful should not determine future treatment attendance. 
There is a strong clinical significance to this finding; the implication being 
that heroin users may still view treatment as important even if ffiey have accessed 
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1V 
this numerous times previously; thus, professionals in drug treatment services 
should view each episode of treatment as significant. 
3.4.4 Conclusion 
This study shows some success for the use of TPB in the prediction of 
attendance intention and its ability to predict actual attendance for drug treatment 
over a six-month period. Interestingly this study provides evidence to suggest that 
subjective norm is significant in the prediction of attendance behaviour. There is 
some argument over the usefulness of subjective norm in the prediction of 
behaviour, yet two studies looking at vulnerable populations have made 
significant findings to suggest that subjective norm can predict behaviour in these 
populations. 
I 
Of the additional variables included in the model neither past behaviour 
(previous drug treatment) nor drug use (clinical variables; heroin use, crack use, 
social relationships) were significant in predicting attendance behaviour though 
drug use was a significant predictor of intention. Subsequently Cox's regression 
analysis showed that individuals that continued to use drugs during treatment 
were more likely to drop out than those that did not use. 
3.5 Summary 
The predictive validity of the TPB warrants further examination for use in 
this population. Intention to attend for drug treatment was, as predicted, 
determined by perceived behavioural control and drug use. Drug use and 
previous drug treatment were included as predictor variables from those 
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highlighted as risk factors in Chapter One; in contrast to what was originally 
hypothesized, neither were significantly predictive of treatment attendance in this 
study. 
The most interesting, and unexpected, finding from this study was that 
attendance behaviour was determined by subjective norm, which is in direct 
contrast to usual theoretical assumptions made by the TPB. One other attendance 
study (Christian & Armitage 2002) supported this outcome, with a population of 
homeless individuals accessing support services, suggesting that vulnerable 
populations may put value on the expectations of others. Clearly this component 
requires ftu-ther empirical attention. 
3.5.1 Next steps 
To follow on from the prediction of treatment attendance, the subsequent 
Chapter will apply the TPB to a population of heroin users attending for drug 
treatment but this time will assess the ability of the TPB to predict heroin use 
intention and behaviour whilst engaging in a drug treatment programme. 
The study will again be conducted over a six-month period, but in addition 
will incorporate four separate data collection points; baseline, I-month, 3-months 
and 6-months, to assess predictive power of the TPB at different time Points 
during drug treatment. Participants will be interviewed at all four time points to 
collect both sub ective and objective data for measurement of ongoing drug use j 




Chapter 4- Application of the Theory of Planned Behaviour to 
Predict Heroin Use During Drug Treatment. 
4.1 Introduction 
Chapter Three provided some support for the TPB as a predictor of drug 
treatment attendance and suggested that continued drug use during treatment was 
indicative of treatment drop out. The continued use of drugs during treatment 
continues to present challenges to drug treatment services thus the identification 
of drug use predictors are important for behaviour change modification. This 
study aims to apply the TPB to investigate predictors of ongoing drug use during 
drug treatment 
4.1.1 Drug Treatment 
The National Drug Treatment Monitoring System (NTA 2007a) for 
England reported 179,628 drugs users were accessing drug treatment by the end 
of March 2006, which is a 43% rise on 2003/4 Figures (126,000). This suggests 
that heroin use is rising and/or more heroin users are accessing treatment. 
Drug users present to treatment with complex mixtures of substance use 
and other related problems, as discussed in Chapter One. Drug treatment is seen 
as an effective way of reducing heroin use (Gossop et al 2003, Prendergast el al 
2002) and mortality (Gibson et al 2008), though reports of continued drug use 
during drug treatment still range from between 20%-70% (Best & Ridge 2003, 
Belding et al 1998). This suggests that drug treatment alone cannot be responsible 
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for behaviour change in this population, 20. Treatment outcomes studies report that 
continued drug use during treatment is a strong predictor of poor treatment 
compliance (Gossop, Duncan & Marsden 2003) and that this could also lead to 
treatment drop out (Booth, Crowley & Zhang 1996). Chapter 3 also supports this 
assumption in that those who continue to use drugs during drug treatment are 1.8 
times more likely to disengage with treatment (see Section 3.3.5.1) than those 
who do not use drugs. 
Chapter Two highlighted, from self-reports of heroin users, that drug 
treatment is seen as an important facilitating factor in becoming drug free and that 
having support from health professionals would make stopping drug use easier. 
However, continued drug use during treatment does still occur and for treatment 
to be effective the variables that predict ongoing drug used need to be identified 
thus enabling behaviour change interventions to be developed. 
4.1.2 TPB Applied to Drug Use 
Reviews generally suggest that the theory of planned behaviour (TPB) is a 
useful predictive framework across a wide range of health behaviours (Armitage 
& Conner 2001) and studies have also examined the TPB in relation to 
recreational drug use2l; for example, cannabis use (Armitage et al 1999, Conner & 
McMillan 1999), ecstasy use (Umeh & Patel 2004), LSD, amphetamine, ecstasy 
20 Fountain et al (2000) report high rates of drug diversion from individuals selling their prescribed 
treatment, which may be suggestive that those individuals have little intention of wanting to stop 
using drugs even though they are accessing drug treatment. 
21 Recreational drug use differs from dependant drug use in that dependant drug use is identified 
through symptoms of tolerance (diminished effect with continued use), withdrawal states, social 
and occupational activities are reduced because of time spent in activities necessary to obtain or 
use the substance, lack of feeling of control over the drug and often use in an isolated way. 
Recreational users use less often, use for enjoyment with peers, have control over the drugs they 
are taking, do not experience withdrawal features and are still able to maintain their usual lifestyle. 
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and cannabis (McMillan & Conner 2003) and abstinence intentions for alcohol, 
drugs and eating disorder during recovery treatment (Morojele & Stevenson 
1994). The following section will review previous examples of studies in which 
the TPB has been applied to the prediction of drug use. 
4.1.2.1. Predicting Drug Intention from TPB Variables 
McMillan and Conner (2003) applied the TPB to predict LSD, 
amphetamine, cannabis and ecstasy use in a sample of students using a 
prospective design with a three-month follow up period. 47% of the sample were 
followed up at 3-months and results suggest that across all drug use behaviours 
attitude and perceived behavioural control were significant independent predictors 
of drug use intentions. Attitude was also a significant independent predictor of 
intention in a study of ecstasy intention conducted by Umeh and Patel (2004) and 
perceived behavioural control was also significant but only through a positive 
interaction with attitude. In contrast Morojele and Stevenson (1994) found 
subjective norm to be the only significant predictor of abstinence intention in their 
study of individuals attending a rehabilitation programme for drug, alcohol and 
eating disorders. 
4.1.2.2 Predicting Drug Behaviour from TPB Variables 
McMillan and Conner (2003), found intentions to be significant in 
predicting LSD, amphetamine, cannabis and ecstasy behaviours explaining 
between 26-49% of the variance in drug use. Conner and McMillan (1999) also 
report intention as the strongest predictor of cannabis use. Both of these studies 
also found perceived behavioural control was only able to increase the variance in 
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behaviour through an interaction with intention; thus was itself not independently 
predictive of drug use behaviours. 
Subjective norm was not included in analysis of behaviour in either of the 
studies by McMillan and Conner (2003) and Conner and McMillan (1999). This 
reflects the assertion made in the meta analysis by Armitage and Conner (2001) 
that subjective norm is seen as the weakest predictor and as such studies have 
chosen to remove it from behaviour analysis. However, two studies have found 
empirical support to suggest a direct subjective norm-behaviour relationship. 
Chapter Three found subjective norm to be the single independent predictor of 
attendance behaviour which builds on earlier findings from Christian and 
Armitage (2002) who found that subjective norm was predictive of attendance at 
homeless services. Results from these two studies suggest that the subjective 
norm component could be important in some populations thus in removing this 
variable from analysis significant developments in the TPB might be getting 
missed. 
4.1.2.3 Limitations in Drug Use TPB Studies 
Armitage et al (1999), Conner and McMillan (1999), McMillan and 
Conner (2003), and Umeh and Patel (2004) and all used student populations to 
predict drug use intentions within their studies. Self reported drug use behaviours 
were reported by Armitage et al (1999), Conner and McMillan (1999), McMillan 
and Conner (2003), Morojele and Stevenson (1994) and Umeh and Patel (2004). 
Morojele and Stevenson (1994) and Umeh and Patel (2004) also only reported 
drug use intentions. The length of follow-up periods varied from between one- 
106 
week (Armitage et al 1999) to six-months (McMillan & Conner 2003) with only 
29% retention achieved by McMillan and Conner (2003) over their six-month 
study period. The limitations found in these studies reflect the overall limitations 
of TPB applications discussed within Chapter One (Section 1.4.3.2) 
4.1.3 Summary 
Consistent with the general studies of the TPB, attitude is a strong 
predictor of drug intention, as is perceived behavioural control. Subjective norm 
has been argued to be the weakest predictor of intention (Armitage & Conner 
2001) though this does not appear to be consistent with findings related to drug 
intentions (Morojele & Stevenson 1994) and has not been included in behaviour 
analysis in some drug use studies (Conner & McMillan, 1999, McMillan & 
Conner 2003). Interestingly, perceived behavioural control is not a significant 
determinant of actual drug behaviours apart from through an interaction with 
intention. Morojele and Stevenson (1994) have suggested that although the TPB 
was developed to predict behaviours; not under volitional control it actually does 
no better than the TRA in the prediction of drug use behaviours. The TPB may be 
useful as a framework for predicting heroin use behaviours; though consideration 
of the limitations of the TPB, in general and, in drug populations need addressing. 
4.1.4 Rationale for the Present Study 
The focus of this study is to use the TPB to explore predictors that are 
associated with intention to stop using drugs and drug behaviour in a population 
of heroin users attending a Substance Misuse Service to start drug treatment. It 
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will also attempt to overcome some of the limitations of TPB studies by including 
prospective measures of actual behaviour in a clinical population. 
As with Chapter Three, this study will incorporate clinical and 
psychosocial predictors of drug use, TPB variables and those highlighted from 
Chapter One; heroin use, crack use, and social relationships (numbers of drug 
using associates). In addition, as the drug treatment strategy is focused on the 
reduction of drug related harms (Department of Health 2001, Home Office 2002), 
injecting behaviour will be included as a measure of risk behaviour and health 
risk. 
To test the validity of the TPB in predicting actual behaviour, drug use 
will be measured by both self-report and objective data. Urine samples taken at 
baseline and follow-up periods will give confirmation of drug using behaviours by 
utilising clinical biological markers of actual drug use. This will reduce the 
potential biases related to self-report and further investigate the effectiveness of 
the TPB in predicting objective behaviours. 
For the TPB to be regarded as a predictive model it is important to show 
that it is able to predict continuous behaviours, heroin use for example, as well as 
single actions, for example attendance at health screening (Rutter 2000, Michie et 
al 2004). Single actions may also have long time periods between behaviours 
hence do not permit investigation into how behaviour might change in between 
follow-up and which variables are associated with change. As a result potentially 
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valuable information about how behaviour changes over a study period can be 
lost. 
The use of multiple outcome measures will enable the assessment of TPB 
in predicting continued drug use during different stages of drug treatment. 
Multiple measures of behaviour have been used by Elliott, Armitage and Baughan 
(2007) and Armitage (2005) to investigate those TPB variables associated with 
behaviour change over time using survival analysis techniques. However, the 
studies did not investigate changes in predictors within time periods, a limitation 
reported by Armitage (2005). This study will use traditional hierarchical 
regression analysis to investigate predictors of drug use at different time periods 
within the study thus building a picture of predictors over time. Therefore to 
assess the predictive ability of the TPB over time, drug use outcomes will be 
measured at four distinct time points within a six month period; baseline, one- 
month, three-months and six-months. 
Only one other study was found 22 that used repeated measures of the TPB 
in this way. Cote, Gogin and Gagne (2004) measured TPB variables four-times 
over a 26-month period to assess the factors protecting smoking abstinence in 
school children. Subjective norm and perceived behavioural control effects on 
abstinence behaviour did not change over time though the interaction of intention 
over time was significant. Smoking abstinence intention was significant at 
baseline and 26 months only, yet in at the latter time point the correlation was 
22 Based on web of Knowledge searches which included keywords 'theory of planned behaviour' 
AND 'repeat* measure*' 'repeat* event*' 'multiple measure" 'multiple event- 'multiple 
outcome*' 
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negative suggesting student's intention to remain abstinent was higher at the start 
of the study period than at the end. The authors conclude that the TPB, as well as 
being a predictive model, could also be a valuable tool for identifying and 
targeting school educational interventions at times that are best placed to reinforce 
abstinence intentions. Thus the findings from the present study may go on to 
highlight important outcomes on which to base clinical interventions, at different 
times, during drug treatment. 
4.1.4.1 Aims 
The aim of this study is to use a longitudinal repeated measures design to 
test the TPBs ability to predict future illicit drug use (heroin) in a clinical sample 
of heroin users, accessing a drug treatment programme using objective biological 
data to confirm drug use outcomes. 
It is hypothesized that: (a) the TPB variables will be able to predict 
intention and behaviour over multiple time periods; (b) that subjective norm and 
the additional clinical variables will account for additional variance in behaviour 
and (c) the predictive validity of the TPB would be further supported in the 
domain of heroin use by using an objective measure of behaviour. 
4.2 Method 
4.2.1 Participants 
The participants in this study are those as described in Chapter Three (see 
Table 3.1). The same population was used for both empirical studies as it enabled 
110 
attendance and drug use intention and behaviour to be assessed simultaneously 
during a treatment programme. 
4.2.2 Study design 
The study was longitudinal in design conducted over a six-month period. 
Initial data were collected at baseline, to coincide with start of drug assessment 
and treatment, with a follow-up periods at one-month (Q), three-months (6) and 
finally at six-months (t4). 
4.2.3 Recruitment Procedure 
Recruitment procedure is described in Chapter Three (see Figure 3.1). 
Structured interviews were undertaken which took approximately 20 minutes to 
complete depending on the literacy of the individuals participating'3 . Participants 
would continue their treatment programme as agreed with their treatment service 
and involvement within the study would have no bearing on the treatment they 
would receive. 
4.23.1 Follow-up Procedure 
Participants were required to provide telephone and mail contact 
information and the name of one other contact person. Consent was also given to 
contact treatment services for details of future treatment appointments so that 
contact could also be made through this route. Multiple contact strategies were 
collected to maximise follow-up communication and subsequent study retention. 
23 Rationale for the use of interviews is discussed in Chapter 3 Section 3.3.3. 
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Participants were contacted either personally or via the clinician involved 
and seen for further data collection at their convenience either coinciding with a 
clinic appointment or as a home visit if preferred. If participants did not attend or 
were unable to be contacted within two weeks of the data collection period then 
that time period was entered as missing data (see Section 4.3.4.6 regarding the 
handling of missing data). Collecting data any later than 2-weeks could 
potentially have biased results as participants would have been in treatment for a 
longer time period and hence more probability of in-treatment variables having 
increased mediating effects on outcomes. A mean of five (range 1-9) contact 
attempts were made per participant per follow-up period. 
4.2.4 Measures 
All measures, with the exception of the demographic information, were 
collected at all four time periods throughout the study. 
Figure 4.1: Follow Up and Study Attrition 
Participants TI 
n--57 
T3 - 50 eligible 
Data Collected n=39(78%) 
Study attrition n= 2 (4%) 
Missed 
follow-up n= 7 (14%) 
Withdrawn from 
study n= 2 (4%) 
T4 - 46 eligible 
Data Collected n=43(93%) 
Study attrition n= 3 (7%) 
Missed 
follow-up n= 0 (0%) 
Withdrawn 
from study n= 0 (O'Yo) 
T2 - 57 eligible 
Data Collected n=44(77%) 
Study attrition n= 5 (9%) 
Missed 
follow-up n= 6 (1 0*/o) 
Withdrawn from 
study n= 2 (41/o) 
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4.2.4.1 Demographics 
Information was collected on demographic outcomes; gender, age, marital 
status, employment and the number of other drug users participants currently had 
contact with (reported as social relationships). Data was collected in the same 
format as that in Chapter Three (see Section 3.3.4.1) 
4.2.4.2 Self-Reported Drug Use 
The measures for self-reported drug use, has been fully described in the 
measures section of Chapter 3 (see Sections 3.3.4.1 and 3.3.4.2). The Opiate 
Treatment Index (Darke et al 199 1) will be used to assess drug use outcomes. 
4.2.43 Objective Drug Use 
In addition to self-reported data on drug use participants also gave urine 
samples to validate self-reported information. It is worth noting that self-reported 
data was given from the past month and objective urine data would only have 
given a positive result, confirming recent drug use, if the drug had been used 
within the time taken for each of the drugs to be metabolised and eliminated from 
the body. In urine samples the detection rates for heroin is 48 hours with a 2-3 
day detection rate for crack cocaine (NTA 2007). As a result discrepancies may 
occur as a result of the data being collected over different time periods, for 
example, if a participant had used heroin 7-days prior to interview it would be 
reported as a positive self-reported score but as a negative urine score. 
Analysis showed that self reported, opiate treatment index scores, and 
objective data, urine results, for the heroin and crack drug categories were highly 
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correlated. For heroin scores; self-reported (SR) at tI and objective scores (OS) at 
tl, r=. 77, p<. 00l; SR and OS at t2, r=. 75, p<. 00l; SR and OR at t3, r=. 70, 
p<. OOI; SRandORatt4, r=. 75, p<. 001. For crack scores; SRand ORat tl, r 
=. 70, p <. 001; SR and OR at t2, r=. 70, p <. 001; SRand OR at t3, r =. 74, p < 
. 001; SR and OR at 0, r= . 84, p< . 001. High internal reliability scores, 
cronbach's a= . 841 and a= .8 88, were seen 
for heroin and crack respectively. 
Chermack et al (2000) report combining data obtained from both objective 
and self-reports is a much more accurate measure of drug use than either method 
alone. This will allow an objective measure of the frequency of heroin and crack 
use rather than a binary negative or positive score, which is of more interest as it 
reflects the amounts of drugs being used. As the self-reported and objective 
measures of heroin and crack use have high internal reliability, a composite heroin 
score and a composite crack score, at each data collection point, will be used for 
analysis. 
4.2.4.4 Injecting Behaviour 
Injecting behaviour was added as a variable in this study to assess whether 
health risk and high risk behaviour is a predictor of heroin use as highlighted by 
Booth, Crowley and Zhang (1996) and Darke et al (2005) in Chapter One. To 
measure injecting behaviour, the injecting Section, part of the HIV risk taking 
4 behaviour section of the Opiate Treatment Index was used (Darke et al. 1991ý , 
This section asks "how many times have you injected drugs in the past month? ". 
The more frequent the injecting behaviour the higher a score is given; hasn't 
24 See Section 3.3.4.2 for reliability and validity for the use of the Opiate Treatment Index. 
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injected=O, once a week or less--I, more then once a week (but less than once per 
day) =2, once a day=3,2-3 times a day=4, more than 3 times a day=5. The higher 
the score in this section relates to the greater the frequency drugs are injected and 
the greater the risks that are associated with this route of administration. 
4.2.4.5 Drug Treatment 
Drug treatment and was collected via a verbal 'treatment tracking' forin, 
used from time 2 onwards, in which participants were asked what type of 
treatment they were receiving, whether there had been any changes to that 
treatment and the dosage of any prescribed medication. This information was 
validated by use of computer records at their drug treatment service. 
4.2.4.6 Theory of Planned Behaviour Variables 
The theory of planned behaviour predictor variables, relating to stopping 
using drugs were measured, at four times points over a six month period, using 
standard itemsý5 (Ajzen 1991) on 7-point scales. 
4.2.4.6.1 Behavioural Intention 
Behavioural intention was measured on three bipolar (-3 to +3) scales 
using the items: 'I intend to stop using drugs in the future definitely do not- 
definitely do, 'I plan to stop using drugs in the future definitely do not-definitely 
do', 'I would like to stop using drugs in the future definitely do not-definitely do'. 
25 Tbe use of standard items rather than belief based measures has been previously discussed in 
Chapter 3 Section 3-3.4.5. 
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The intemal reliability of the scales was good with Cronbach's a =. 929, cc =. 935, 
a =. 928, a =. 933 over the four time periods. 
4.2.4.6.2 Attitude 
The attitude measure was assessed with four items asking participants to 
rate on a bi-polar scale (-3 to +3) whether 'my stopping using drugs in the future 
is/would be 'unpleasant-pleasant, nasty-nice, not enjoyable-enjoyable and 
unsatisfying-satisfying'. The attitude scale had good internal reliability over the 
study period Cronbach's a= . 918, cc = . 914, a= . 863, a= . 915 respectively. 
4.2.4.6.3 Subjective Norm 
Subjective norm was assessed using the direct measure (n); 'The people 
who are important to me think I should not stop using drugs in thefuture- should 
stop using drugs in the future' followed by a motivation to comply measure (m); 
'With regard to stopping using drug in the future, how much do you want to do 
you what those important to you think you should not at all - very much so'. 
Both scales were scored on a 7-point unipolar scale and multiplied together to 
produc3e a subjective norm score. 
4.2.4.6.4 Perceived Behavioural Control 
Perceived behavioural control was measured by scoring three items on a 7- 
point unipolar (I to 7) scale 'If I wanted to I could easily stop using drugs in the 
future strongly disagree-strongly agree'and 'How confident are you that you will 
be able to stop using drugs in the future not very confident-very confident' 'My 
stopping using drugs in the future would be difficult-easy' Cronbach's alpha 
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showed that the scale possessed good internal reliability for time one, two and 
three a= . 604, a= . 642 and a= . 661, however the final measure 
had a poorer 
internal reliability of a= . 461 but was still included in the analysis. This could 
possibly be related to changes in perceived behavioural control during the process 
of treatment, especially if illicit drug use continues, the level of control over 
future drug use may not be as strong as perceived when treatment was first 
accessed. 
4.2.5 Analysis 
The focus of the analysis was to test the theory of planned behaviour and 
its power to predict intention to stop using drugs in the future and to explore 
which predictor variables would be significant in the predicating future behaviour. 
A correlation matrix of predictor variables was computed and multiple regression 
used for data analysis. 
Missing data caused by study attrition or withdrawal from the study (see 
Figure 4.1 for flow of missing data and study attrition) was imputed by way of 
'last-observation-carried-forward', which will serve to reduce the potential bias in 
analysis. This method has been used in substance misuse research (Hutchinson et 
al 2000, Wasserman et al 1998) and is seen as a valid way of dealing with missing 




See Chapter 3 (Table 3.1) for baseline demographic data on participants. 
Fifty seven participants consented to take part in the study of those 43 (75%) were 
successfully followed up over the six-month study period. Figure 4.1 shows the 
flow of study attrition and missing data at each time point. 
Of the 43 who remained in the study; 37 continued to have contact with 
the Substance Misuse Service for drug treatment and six had been discharged 
(Three had planned discharges following successful completion of a 
detoxification programme; unfortunately two of the three had relapsed by the end 
of the study period. One participant never actually started any prescribed drug 
treatment and the remaining two were discharged from the service due to non- 
attendance and ongoing illicit drug use). 
Four participants withdrew from the study and 10 were lost to follow-up; 
three were in prison, two had moved away from the Sheffield area and the 
remaining five were unable to be contacted. 
4.3.2 Drug Treatment 
Of the 37 participants that remained in drug treatment at six months, 27 
(73%) had used heroin in the past month with 13 (35%) of those continuing to use 
heroin on a daily basis. Multiple regression analysis confirmed that being in UI 
treatment at t2, t3, and 0 was not significantly predictive of stopping heroin at six 
,I 
months, with drug treatment only accounting for 9% of the variance (F = 1.52, p> 
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. 10). Drug treatment as a predictor of future heroin use was therefore removed 
from the remainder of the analysis in order to reduce the number of variables 
being assessed. 
4.3.3 Correlations Between Measured Variables at Time 1 
Table 4.1 shows the intercorrelations, means and standard deviations 
among the variables. It can be seen that behavioural. intention is, as expected, 
correlated with peiceived behavioural control (r = .41, p< .0 1), attitude (r = . 43, 
p< . 05) but was negatively correlated with crack use (r = -. 3 9, p< .0 1) and social 
relationships (r = -. 24, p< . 05) suggesting that the higher the use of crack and the 
increased number of drug associates you have the less likely your intention is in 
stopping using drugs in the future. 
Heroin use was not correlated with any of the theory of planned behaviour 
variables but was associated with both crack use (r = . 25, p< . 05) and social 
relationships (r=. 30, p <. 05). Crack use in turn was correlated with behavioural 
control (r = -. 40, p< . 01) suggesting the more crack that is used the less control 
you have in being able to stop using drugs in the future, as heroin, crack is also 
associated with drug using relationships (r = . 32, p< .0 1). 
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4.3.4 Predicting Behavioural Intention 
The predictive validity of the theory of planned behaviour was tested using 
hierarchical regression (see Table 4.2). The first step included the TPB variables; 
attitude, subjective norm and perceived behavioural control, which accounted for 
23% of the variance in behavioural intention with attitude being the only 
significant independent predictor (P = . 30, p< . 05). The second step added 
predictors from previous treatment outcome studies discussed in Chapter One, 
heroin use, crack use, injecting behaviour and social relationships. The additional 
predictors improved the variance to 31% but added nothing to the final model 
with only attitude (P = . 29, p< . 05) emerging as a significant predictor of 
behavioural intention. 
4.3.5 Predicting Future Drug Use 
To test the predictive ability of the theory of planned behaviour to predict 
drug use an initial multiple regression analysis was conducted regressing heroin 
use at t4 with behavioural intention, attitude, subjective norm and perceived 
behavioural control. Results showed the TPB variables accounted for 25% of the 
variance in predicting drug use with subjective norm being the only significant 
predictor (, 6 = -. 30, p< . 05). As you would not normally expect subjective norm 
to be predictive of behaviour ftu-ther exploratory regression analysis was 
conducted. Stepwise regression rather than the traditional hierarchical regression 
analysis will be used to further explore predictors of behaviour. Hierarchical 
regression builds a model based upon what past research might tell you; hence 
you include variables in the order of their importance to build a model. As there is 
no current research that has examined the predictive ability of the theory of 
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planned behaviour in relation to stopping using heroin and as subjective norm was 
unexpectedly shown to be a significant predictor of attendance behaviour, in 
Chapter Two, stepwise methods are helpful as they help build exploratory models 
where there is no previous research base (Field 2002). 
Table 4.2: Predicting Behavioural Intention 
Variables R2 AR 2F 
Step 1 . 23 . 23 4.99** 
Attitude . 30* 
Subjective Norm 



















* <. 05 
** 
Stepwise methods make decisions about which predictor variables are 
entered into the model based on mathematical criterion, for that reason this 
method is often viewed as having limitations as it is the computer rather than the 
researcher that searches for the predictor that best predicts the outcome variable. 
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Forward methods add only those variables that best predict the outcome variable 
and backward methods add all variables into the model removing variables at 
different steps that contribute the least until a final model fit is calculated (Field 
2002). Backwards regression will be used in this study to assess the contribution 
of each variable on the final model. The rational for this being that it will enable 
the least important variables to be removed thus might give a sense of which of 
the variables may be the least significant when attempting to understand heroin 
use behaviour change in clinical settings. 
Analysis will be undertaken to investigate predictive variables associated 
with heroin use at t2,0 and t4 to examine different predictors at different time 
points. The backward multiple logistic regression models includes all the baseline 
measures for each of the variables; behavioural intention, subjective norm, 
perceived behavioural control, heroin and crack use, injecting behaviour and 
social relationships, at step one. 
43.6 Predicting Drug Use at Time 2 (one month) 
Regression analysis using a backward stepwise method was used to 
explore which variables were predictive of stopping drug use at one month; four 
steps were taken to get to the final model. 
Step I of the regression model with all the predictors included (see Table 
4.3) accounts for 49% of the variance with heroin use (fl = . 48, p< . 01) and 
subjective norm (p = -. 3 1, p< .0 1) significantly associated with heroin use at one 
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month. Heroin use at baseline is associated with heroin at one month and the 
lower the perceived social pressure to stop using drugs at baseline the less likely 
you are to stop using at one month. Step 2 removes injecting behaviour, which 
has no impact on the variance, and adds perceived behavioural. control (, 6 = -. 27, p 
< . 05) along with subjective norm and 
heroin use as significant independent 
predictors. 
Crack use and intention were removed at steps three and four respectively, 
the significant predictors remaining the same over the final two steps. The final F 
=11.58, (df = 1,49, p< . 01) with four predictors accounting 
for 48% of the 
variance. The strongest independent predictor of heroin use at one month is 
heroin use at baseline (, 6 = . 43, p< . 01), the next being subjective norm (, 6 = -. 3 1, 
p< . 01) and perceived behavioural control (P = -. 30, p< . 01). Thus ongoing 
heroin use at one month was predicted by heroin use at baseline. Those with 
lower levels of perceived control and social pressure to stop using heroin were 
more likely to still be using heroin at one month. 
Table 4.3: Predicting Drug Use at Time 2 
Predictors at tl R2 AR2 F 
Step 1 . 49 . 49 6.51** 
Behavioural intention -. 12 
Subjective Norm -. 31** 
Perceived behavioural control -. 27* 
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* p<. 05 
**p <. 01 
43.7 Predicting Drug Use at Time 3 (three months) 
Backward regression was conducted resulting in three significant 
predictors of heroin use at three months over 5-steps (see Table 4.4). 
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Steps one and two results in heroin use being the only significant predictor 
of heroin use at three months accounting for 38% of the variance after perceived 
control was removed. At step three crack use is removed due to insignificance 
and as a result the variance remains the same. Behavioural intention (. 8 = -. 25, p< 
. 05) become a significant predictor alongside heroin use (, 6 = . 37, p< .0 1), once 
crack use was removed from the model. Step four of the regression removes 
injecting behaviour, which leaves, at step five, three independent significant 
predictors, after removal of social relationships, accounting for 34% of the 
variance in stopping heroin use at three months (R 2= . 34 F=8.83, df = 1,50, p< 
. 01). 
As at one month both heroin use (, 6 = . 43, p< .0 1) and subjective norm (, B 
-. 26, p< . 05) are significant predictors of heroin use at three months yet 
perceived behavioural control, a significant predictor of heroin use at one-month, 
was removed from the model at step one as non significant. Behavioural intention 
(, 6 = -. 28, p< . 05) was also a strong predictor of heroin use at three months hence 
those that had lower levels of intention to stop were associated with on going 
heroin use at three months. 
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Table 4.4: Predicting Drug Use at Time 3 


































. 38 . 00 4.98** 
. 38 . 00 6.04** 
















Social relationships . 20 
Step 5 . 34 -. 04 8.83** 
Behavioural intention -. 28* 
Subjective Norm -. 26* 
Heroin use . 43** 
*p<. 05 
**p<. Ol 
43.8 Predicting Drug Use at Time 4 (six months) 
Steps one through four of the regression results in only heroin use being a 
significant predictor of heroin use at six-months accounting for 32% of the 
variance (p = . 39, p< . 01) the removed variables being, injecting behaviour, 
social relationships and perceived behavioural control in that order (rable 4.5). 
At step five behavioural intention was removed as was subjective norm at 
step six leaving heroin (P = . 37, p< . 01) and crack use (, 6 = . 26, p< . 05) to 
account for 26% of the variance in the final model (R 2= . 26, F=9.02, df= 1,5 1, 
p< .0 1) with none of the theory of planned behaviour variables being significant 
predictors of heroin use over a six-month period. It is therefore the drug 
variables, heroin and crack, that are independently predictive of drug use over the 
longer term. 
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Table 4.5: Predicting Drug Use at Time 4 


























. 33 . 33 3.32** 
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. 30 -. 01 7.16** 








** p <. 01 
4.4 Discussion 
4.4.1 Summary of Findings 
Heroin use continued throughout the six-month study with 35% of 
participants still using drugs on a daily basis thus drug treatment was not 
predictive of stopping heroin use over a six-month period. 
The TPB was able to predict objective drug use behaviour over the short 
term (3-months), PBC and intention predicting behaviour at one-month and three- 
months respectively. As in Chapter Three, subjective norm was significant in 
predicting behaviour at both one month and three months. Heroin and crack use 
were independent predictors of heroin use at six months. Attitude was the single 
significant predictor of drug use intention. The use of multiple time points 
highlights the changes in predictors over time that would not have been made 
apparent by using baseline to end-point data analysis. 
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4.4.2 Prediction of Intention 
None of the clinical items were significant in predicting intention to stop 
using drugs. Attitude was significantly predictive of drug use intentions, which is 
congruent with previous studies on drug use (see Section 4.2.2.1). This also 
supports the findings in Chapter Two (see Section 2.4.1) that heroin users 
reported a high number of positive behavioural beliefs about stopping using 
drugs. However, in contrast, this study does not support the findings of McMillan 
and Conner (2003), Armitage et al (1999), Conner and McMillan (1999) and 
Umeh and Patel (2004), as perceived behavioural control was a non-significant 
predictor of drug use intention. 
4.43 Prediction of Behaviour from TPB Variables over Six-Months 
The present study found some evidence to support the predictive validity 
for the TPB in the short-term, 3-months, but not over a six-month period once 
clinical variables were included in the model. Perceived behavioural control and 
subjective norm contributed to the final model, which contributed to 48% of the 
variance in drug use at one month into drug treatment and intention and subjective 
norm were significant predictors of drug use behaviour at three-months. None of 
the TPB variables were able to predict drug use behaviour over a longer 6-month 
period. Therefore intervention based upon psychological variables may only be 
effective in the short to medium term with other variables predictive of continued 
drug use after that time. With regards to clinical variables, heroin was predictive 
of future heroin use at all time periods and crack use was predictive of heroin use 
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a time four (six-months), which supports the hypothesis that the additional clinical 
variables will explain additional variance in drug use behaviours. 
This finding suggests that psychological interventions might be best 
targeted at the very start of drug treatment; as interventions done further into 
treatment, especially if drug use continues, could prove less effective. Hence, this 
might give some support to the proposal that individuals should be retained in 
treatment for at least three-months; however, if change has not occurred during 
this time and drug use continues future outcomes for those individuals might be 
poor. 
4.4.4 Prediction of Drug Use Behaviour from Subjective Norm 
In contrast to the theory of planned behaviour assumptions subjective 
norm was able to predict objective behaviour over a three -month period. This 
supports the findings from Chapter 3 that, within the current study population, 
subjective norm has a strong influence on behaviour, at least in the short-term. 
The acceptance by some that subjective norm is the weakest predictor of 
intention, and the assumption that it has no bearing on behaviour, appears to have 
resulted in subjective norm being excluded from analysis (see Armitage & Conner 
(2001) for full review). Interestingly, of the drug studies reviewed only Armitage 
et al (1999) included subjective norm as a determinant of drug use, though it was 
not a significant predictor of cannabis behaviour. This supports the need for 
further empirical investigation of the subjective norm-behaviour relationship. 
132 
4.4.5 Prediction of Drug Use Intention and Behaviour from Perceived 
Behavioural Control 
This study supports Morojele and Stevenson (1994) in that PBC is not a 
significant predictor of behavioural intention and has contrasting findings to that 
of Conner and McMillan (1999), Armitage et al (1999) and McMillan and Conner 
(2003) in that it was able to predict drug use behaviour at one-months. 
One consideration may be that in the studies by Conner and McMillan 
(1999), Armitage et al (1999) and McMillan and Conner (2003) the target 
population were recreational drug userS26 as opposed to the current study where 
the population were using heroin in a dependant daily pattern. Ajzen (1991) 
proposes that people are likely to form strong intentions to perform behaviours 
when they believe they have the necessary resources and opportunities to perform 
them. In terms of the PBC - behaviour relationship this study found PBC to be 
predictive of behaviour only in the short term and not consistently over time. 
Conner and McMillan (1999), Armitage et al (1999) and McMillan and Conner 
(2003) report PBC as a non-significant predictor of drug use. The control beliefs 
that determine subsequent perceived control and behaviour may also differ in 
dependant drug users with the identification of such variables as withdrawal 
symptoms and association with others as strong barriers to behavioural 
achievement this could impact on their perceived ability to have control over 
future drug use. 
26 College/University students 
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Nonetheless, this does call into question the validity of the TPB over and 
above the TRA. Application of the TPB to non-volitional behaviours (Ajzen 
1991), in this case drug use, does not report PBC as a significant predictor of 
behaviour. 
4.4.6 Drug Use-Behaviour Relationship 
Heroin use at baseline was the strongest significant predictor of future 
drug use at one-month, three-months and six-months which is congruent with 
previous findings by Gossop, Duncan and Marsden (2003) and Gossop, Stewart 
and Marsden (2006). Crack use at baseline was predictive of continued heroin use 
at six-months which supports Williamson ct al (2007) and findings from Chapter 
One (Section 1.2.3) that cocaine 27 use at the start of treatment is a significant 
predictor of poor long-term outcomes. Findings from Chapter Three also support 
this assumption in that ongoing drug use during treatment was found to increase 
the risk of non-attendance for treatment and treatment dropout (see Section 
3.3.5.1). In this current study there was a significant correlation between crack 
use at t1 and t4 (r = . 61, p< . 01), heroin use at tl and crack use at t4 (r = . 37, p< 
. 05), heroin and crack use at t4 (r = . 43, p< .0 1). 
Interventions based around reducing ongoing crack use during treatment 
are recommended if outcomes for drug treatment are to be improved. It is clear 
that the use of crack by heroin users in treatment has negative outcomes for 
treatment and the individual. 
27 TIiS is an Australian study and the use of injected cocaine powder significantly dominates 
where as in the UK users tend to use crack-cocaine. The associated risks from each cocaine 
derivative are viewed similarly. 
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4.4.7 Conclusion 
This study provided mixed results for the application of the TPB in 
relation to stopping heroin use during treatment suggesting that the TPB might be 
cffective in the short-term though is not predictive of continued drug use over six- 
mondis. 
Attitude is the single significant independent predictor of intention to stop 
drug use. Subjective norm was the most stable TPB predictor of drug use 
behaviour over three-months whilst the strongest predictor of heroin use at six 
months was heroin and crack use at baseline. The TPB enabled moderate short- 
term prediction of behaviour; and this may have implications, as it implies that 
psychological predictors of behaviour might be best targeted at early stage drug 
interventions, application any later could result in poor prognosis in the long term. 
Focusing on normative beliefs especially may have the biggest impact in drug use 
behaviour. 
Drug substitution treatment may be effective in reducing drug use; 27% of 
the participants were not using heroin at six-months, though in contrast to 
inferences made by Booth, Crowley and Zhang (1996), in Chapter Two, retention 
in treatment is not significantly predictive of stopping drug use altogether. 
4.5. Next Steps 
The final Chapter of this thesis, Chapter Five, will consider the overall 
aims of the thesis and examine whether those aims have been met. It will draw 
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together the main findings from the studies; follow with a discussion of the 
limitations of the study and future research considerations that might be apparent 




Chapter 5- Key Findings and Developments, Study Critique and 
Future Research Considerations. 
5.1 Aims 
The aims of the thesis were to examine whether the TPB would be suitable 
for use with a population of heroin users and to assess the use of the TPB as a 
predictor of drug treatment attendance and ongoing drug use. Moreover the thesis 
sought to consider the inclusion of clinical variables, the use of self-reported 
versus objective measures of behaviour and to assess the predictive capability of 
the TPB over time and changes over time by using multiple time measures. The 
following discussion will assess the extent to which the aims of the thesis have 
been met. 
5.2 Key Findings and Developments 
5.2.1 Application of the TPB to Heroin Users 
The findings presented in Chapter One (Section 1.4.3.1) indicate that no 
previous studies had applied the T? B to a population of heroin users. One of the 
aims of the present thesis was to determine the extent to which the TPB could be 
applied to this domain by firstly undertaking interviews with heroin users. 
Results from Chapter Two suggest that heroin users are able to communicate 
beliefs about stopping drug use within the framework and constructs underlying 
the TPB. Moreover, the barriers to stopping drug use were congruent with some, 
though not all, predictors highlighted in Chapter One (Section 1.2) in particular 
the association with drug using peers. Importantly, drug treatment and receiving 
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professional support were highlighted as facilitating factors for heroin use 
behaviour change and thus provided a sound rationale for exploring the 
applicability of the TPB in predicting behaviour change in heroin users accessing 
drug treatment. Further, the structure of the interviews has the potential to be 
used as a clinical intervention during drug treatment. Heroin users were able to 
specify salient factors associated with behaviour change thus these beliefs could 
be targeted during clinical appointments with substance misuse health 
professionals. The use of the TPB in behaviour change intervention will be 
addressed later in this chapter. 
5.2.2 Predictive Utility of the TPB 
To summarize, Chapters Tbree and Four examined the utility of the T? B 
for predicting intention to attend drug services and the subsequent stopping of 
drug use during treatment. Intention to attend drug treatment was predicted by 
perceived behavioural control and attitudes were predictive of stopping future 
drug use. Taking into account Cohen's (1988,1992) qualitative indices for 
interpreting effect sizes this finding is considered to have a large effect size thus 
supporting the hypotheses that the TPB is a good predictor of attendance and drug 
use intentions. 
The TPB was able to predict attendance behaviour over six-months, with 
subjective norm emerging as a significant independent predictor. The TPB also 
predicted heroin use behaviour over three-months with intention, perceived 
behavioural control and subjective norm emerging as significant predictors. Tbus, 
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this thesis has further extended the application of the TPB to a clinical population 
of hard-to-reach, vulnerable and under-researched group; namely, heroin users. 
5.2.3 Subjective Norm - Behaviour Relationship 
An interesting finding to emerge from this thesis is the importance of 
subjective norm in the prediction of behaviour. In the TPB the subjective norm 
component has been argued to be the weakest predictor of intention and has no 
role to play the prediction of behaviour unless mediated by intentions. However, 
the normative component had a direct effect on behaviour in this thesis. Chapters 
Three and Four have both showed subjective norm to be a significant independent 
predictor of treatment attendance and predictive of drug use behaviour at one 
month and three months 
The impact of subjective norm on behaviour has also been observed in 
previous TPB research. For example, Christian and Armitage (2002) and more 
recently Christian, Armitage and Abrams (2007), have shown subjective norm to 
predict homeless peoples' behaviour and suggest that in this population situational 
and social processes, as distinct from personal evaluations, might strongly affect 
behaviour (Christian, Armitage & Abrams 2007). There appears to be a pattern 
emerging within potential vulnerable populations; that subjective norm is a strong 
predictor of behaviour in these two domains is interesting. 
Societal norms may cast drug use as an unacceptable behaviour, which can 
lead to feelings of stigma and alienation. Stigma can be defined as a characteristic 
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of persons that is contrary to a norm of a shared unit, where norm is defined as a 
shared belief that a person should behave in a certain way (Ahern, Stuber & Galea 
2007). Thus being a drug user in a social context where drug use is frowned upon 
may lead to conformity with other drug users. Ahern, Stuber and Galea (2007) 
found that marginalized drug users experience high levels of stigma and 
discrimination and that this is also associated with poor mental and physical 
health. The concept of stigma and social isolation is also discussed by Christian, 
Armitage and Abrams (2007), in that the sense of isolation from society may lead 
to a greater connection or social identity with peers and that this common identity 
may provide the basis on which to succumb to the norms of the group. 
Social identity theory focuses on both the psychological and sociological 
aspects of group behaviour and is concerned with when and why individuals 
identify with, and behave as part of social groups (Tajfel & Turner 1986). Heroin 
users might see themselves as outside of, or rejected by, societal norms, i. e., due 
to criminal activity, which may actually discourage initial attendance at health or 
social services due to fear of reprisal. However, once engaged, they might be 
influenced by the normative influences of health professionals (Ahern, Stuber & 
Galea 2007). Chapter Two identified having support from health professionals as 
being a facilitating factor in stopping drug use. Previous research has considered 
the impact of social influence in the context of the TPB, within other behaviours, 
and has found that identification with a group is a significant predictor of 
intention. For example, Terry, Hogg and White (1999) applied social identity and 
group norms to household recycling, Conner and McMillan (1999) applied 
141 
descriptive norms to cannabis use, Terry and Hogg (1996) applied group norms 
and group identification to heath-related behaviours, Fekadu and Kraft (2002) 
applied descriptive norms and group norm to condom use and Fielding et al 
(2008) group norms and group identification to agricultural practices. These 
studies provide evidence that that 'group norms' have an impact on intention for 
those individuals that that identify with the group in question. Though social 
influence has been shown to exert a strong relationship on intention the same 
cannot be said for behaviour with most of the aforementioned studies not 
extending analysis to the prediction of behaviour, the exceptions being Conner 
and McMillan (1999) and Fielding et al (2008) both of whom reported non- 
significant results. This is disappointing as this is an area of particular interest 
given the findings of this thesis. Nonetheless, it seems likely that when 
behaviours have significant social implications, particularly in the context of 
heroin use and the high-risk behaviours associated with it, that normative and 
social identity considerations might be particularly relevant. Thus further 
empirical research might want to focus on the degree to which heroin users see 
themselves as being stigmatized by others or occupying a social identity and the 
subsequent influence this may have on heroin use intention and behaviours. 
One important consideration for this section, and a consideration for 
further work on the subjective norm component would be to differentiate between 
the relevant referents in empirical applications. Chapter Two identified salient 
normative influences on stopping drug use for example, family, health 
professionals and non-drug users, as well as other drug users and drug dealers. 
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However, in this thesis, as with the two Christian studies (Christian, Annitage & 
Abrams 2007, Christian & Armitage 2002) direct measures of subjective norm 
were utilised rather than belief based measures; thus it would be difficult to 
distinguish which referent each participant was considering 'important' at the 
time. If we are to think about the impact of subjective norm on behaviour further, 
exploration of these concepts, perhaps extending the TPB with the addition of 
social identity variables, could be considered. 
5.2.4 Past Behaviour and the use of Clinical Variables 
This thesis ftuther extended the use of the TPB by including both 
measures of past behaviour and clinical variables with the expectation that this 
would build a more representative picture of drug use behaviour by incorporating 
variables taken from previous treatment outcome studies alongside TPB 
constructs. The rationale for this being if we could identify patterns of clinical 
and psychosocial, variables that predict drug use behaviour interventions could 
then be developed to help modify behaviour change. The additional variables 
were able to explain additional variance in heroin use behaviour though not in 
attendance behaviour. 
Past behaviour has been shown to be a strong predictor of intention and 
behaviour explaining variance over and above that accounted for by the TPB 
variables (Ajzen 1991, Conner & Armitage 1998), explaining on average a further 
13% of the variance in behaviour (Conner & Armitage 1998). This study 
supports that assumption for heroin use behaviour only. Performance of 
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behaviour may bring subsequent behaviour under habitual processes and thus 
make subsequent behaviour more likely. However, the results might suggest that 
the number of previous treatment episodes had little impact on future attendance. 
In contrast, daily use of heroin may become under habitual control and thus has 
consequences for future heroin use. 
Previous attendance behaviour is therefore not important for drug users 
considering future treatment, which again supports self-reports from heroin users 
discussed in Chapter Two, that drug treatment is viewed as an important 
facilitating factor. Theses findings have important implications for clinical 
practice. 
Previous drug treatment outcomes studies, for example those discussed in 
Chapter One (Brewer et al 1998, Hser et al 1999, Darke et al 2005), suggest that 
previous treatment is a significant predictor of poor treatment outcomes and 
treatment dropout. This study contradicts those findings and actually opens up 
avenues for clinical development whereby previous treatment episodes are not 
important for future treatment and therefore strategies to improve treatment access 
may still be helpful. Once in treatment the issue of continued drug use poses a 
significant challenge. Heroin, and the use of crack-cocaine, had significant 
implications for treatment outcomes. This study supports previous research 
(Booth, Crowley & Zhang 1996, Brewer et al 1998, Darke et al 2005, Gossop, 
Duncan & Marsden 2003), and findings from Chapter Three, suggesting that 
heroin and crack use is related to ongoing drug use and has implications for poor 
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treatment compliance and treatment dropout altogether. The combination of 
heroin and crack use in particular is strongly suggestive of poor outcomes at six- 
months. Interventions are required that focus on those individuals that attend for 
treatment with concurrent poly-drug use. 
5.2.5 Objective Measures of Behaviour 
In order to overcome one of the limitations of the TPB, as discussed in 
Chapter One, objective measures of behaviour were included in both empirical 
Chapters in an attempt to improve the predictive validity of the TPB. Self reported 
behaviour data are vulnerable to a number of biases and so testing the predictive 
validity of the TPB with objective measures of behaviour is important. Armitage 
and Conner (2001) found that out of 154 applications of the TPB only 19 studies 
utilised objective measure of behaviour, which calls into question the usefulness 
of the TPB in predicting actual behaviour. The variance in actual behaviour over 
those 19 studies was 20%, as opposed to 31% variance across self-reported 
behaviours (44 studies). The TPB accounted for between 26% and 48% of the 
variance in behaviour using objective measures thus, the R2 values are between 6 
and 28 points greater than those found by Armitage and Conner (2001) and higher 
values than found with self-reported behaviours. This also supports earlier 
research conducted by Elliott, Armitage and Baughan (2007) in which they found 
objective behaviour measures to account for 31%-39% of variance in driving 
behaviours. 
145 
An explanation for the high variance scores, in this thesis, could be due to 
the reliable behavioural measures. Participants were aware that urine screens 
were being collected, alongside self-reported drug use; hence the need to under or 
over report may have been reduced as a result. Attendance at appointments are 
recorded by clinical staff, thus you would expect this to be a reliable confirmation 
of treatment attendance. A second explanation could be the use of interviews 
rather than questionnaires, participants were reminded that information collected 
was confidential and would not impact on the treatment they were receiving. In 
addition prompts and clarification could be obtained for all information received 
from self-rcports. However, it should be recognised that the use of interviews is 
more time consuming than the traditional use of questionnaires in TPB research. 
Chcrmack ct al (2000) suggests that combining data obtained from both 
objective and self-reports is a much more accurate measure of drug use than either 
method alone and this suggestion was adopted in Chapter Four for drug use 
behaviours. The correlations between self-reported and objective heroin and crack 
use behaviour were high and hence the combined measure of drug use had high 
internal reliability scores. The combined score also objectively reflected the 
frequency and intensity of heroin and crack use as opposed to a, positive and 
negative, binary score outcome which is more significant in clinical terms when 
assessing the level of risk behaviour and subsequently when considering 
predictors of drug use outcomes. The objective behaviour relationship in this 
thesis exceeds what would be considered a large size effect, thus these findings 
146 
further support the use of objective measures; consequently the TPB's ability to 
predict actual behaviour in this context is highly significant. 
5.2.6 Use of Repeated Behaviours and Multiple Time Measures 
This thesis used a longitudinal design over six-months, the rationale for 
this, as per the TTM (Prochaska & DiClemente 1986) is that for behaviour to 
change and be maintained a period of no less than six-months is required. This 
also addresses one of the previous limitations of the TPB by investigating the 
models ability to predict intention and behaviour over time. The addition of 
multiple measures of behaviour, implemented within this thesis, supports, and 
builds on, previous work by Armitage (2005) and Elliott, Armitage and Baughan 
(2007) particularly for repeatable behaviours and predicting time to event, for 
example, attendance for exercise and exceeding the speed limit, respectively. The 
use of survival analysis techniques is a relatively new development within this 
field and findings from Chapter Three showed that intention was able to predict 
attendance behaviour, with increased intention associated with a decrease in 
hazard function (treatment dropout), and that increased drug use was associated 
with an increase in hazard function. These findings indicate that clinical 
interventions aimed at increasing intention or reducing drug use could improve 
treatment contact. 
As well as examining the applicability of the TPB over six-months, 
Chapter Four also included multiple outcome measures. The rationale for this 
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was that it allows investigation into behaviour change over long and short-term 
periods to examine changes in predictors of heroin behaviour over time. 
The findings from Chapter Four has significant clinical implications and 
implications for the application of the TPB in general. In terms of the TPB, if only 
a single observation had been utilised at time four (six-months) it would have 
shown the TPB to be a non-significant predictor of heroin use behaviours when, 
in fact, the TPB was a significant predictor of behaviour at one and three months. 
In terms of clinical implications a single observation would have missed some 
significant observations at time two and three highlighting that cognitive variables 
are important, at least in the short-term. It also found that different predictors 
became salient at different times during drug treatment; subjective norm and 
perceived behavioural control at time two (one-month) and subjective norm and 
intentions at time three (three-months). Cote, Gogin and Gagne (2004) found 
similar results when they used multiple measures over 26-months in that changes 
in smoking abstinence intention were apparent over time. Hence, as well as being 
a predictive model, the TPB could also be a valuable tool for identifying and thus 
targeting interventions to variables or times that are best placed to reinforce 
behaviour change. 
5.2.7 Application of the TPB in Behaviour Change Interventions 
According to the TPB efforts to change behaviour need to be targeted at 
behavioural, normative and control beliefs; thus belief changes should reflect 
more positive attitudes, subjective norm and perceived behavioural control which 
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in turn enhance intentions and increase the likelihood that the behaviour will be 
performed (Ajzen 1991). A systematic review of the TPB and behaviour change 
interventions has been conducted by Hardeman et al (2002) which identified 30 
papers describing 24 distinct interventions, 21 of which were health-related. Most 
interventions were targeted at university/college students; the interventions were 
often based on selected TPB components only and included such techniques as 
giving information, persuasion, increasing skills, goal setting, modelling, 
rehearsal of skills, planning and social encouragement/support. Study designs 
were mainly randomised control trials; follow-up was variable with periods of less 
than one-week to more than six-months2s. Tbirteen studies reported interventions 
on change in behavioural intervention with half of those finding change in the 
right direction and 13 reported on behaviour with two-thirds finding positive 
behaviour change. 
The studies included within the meta-analysis were reported to be of poor 
quality; incomplete reporting of dropout limiting the feasibility and acceptance of 
the intervention and generalisability of the findings; reliability of the studies were 
called into question due to poor measurement of the TPB components, commonly 
one item, and one-third of studies did not report reliability measures; 14 out of 18 
studies measured behaviour by self-report and most studies failed to test all TPB 
components. The authors conclude by stating that whilst the TPB may have 
potential for developing behaviour change intervention effect sizes were generally 
small. As the TPB fails to state which strategies are used to change predictors 
29 The exact lengdi of follow-up was not specifically reported. 
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findings from this study are difficult to generalise due to the heterogeneity of the 
interventions included. 
Fife-Shaw, Sheeran and Norman (2007), more recently, used statistical 
simulations to assess how much change in intention and behaviour is engendered 
by changes in evaluations of the behaviour, perceptions of social control and 
control over the performance. The study enlisted university students to self-report 
on 30 behaviours over a two-week period using questionnaires. Statistical 
simulations maximised the values of attitudes, subjective norms and perceived 
behavioural control to assess whether increases in constructs were reflected in 
improved intention and behaviour outcomes compared to original values. 
Findings indicated that maximising each of the predictors produced significantly 
stronger intention scores than those originally observed and that maximising 
perceived behavioural control scores increased behaviour after maximising 
intention scores but that maximising subjective norm did not increase 
performance. The mean proportion of participants who performed the behaviours 
increased from 46% to 74% under maximization which suggests that the TPB 
could provide a useful basis for behaviour change intervention. However, this 
does not provide evidence to suggest which behaviour change strategies are most 
likely to stimulate change; rather it just gives an example of what could happen if 
effective strategies are able to increase construct values. Further limitations to 
this study, also fit into those previously discussed within Chapter One, the use of 
student samples, a short-follow-up period and self-reported behaviour measures. 
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The clinical and theoretical implications of the findings of this thesis 
suggest that different beliefs may become salient at different time points, or under 
different conditions. Longitudinal studies utilising multiple TPB measures could 
assess more regular changes in beliefs over time which, if identified, could 
become the basis of clinical intervention targeted towards behaviour change. The 
meta-analysis by Hardeman et al (2002) and study by Fife-Shaw, Sheeran and 
Norman (2007) suggest that the TPB could be used as a basis for intervention, 
although further studies are required to address strategies that might provoke 
behaviour change 29 . 
5.3 Critique of Present Thesis 
There are a number of possible limitations that should be addressed; 
firstly, sample size and study retention, secondly, the non-inclusion of drug 
treatment in the analysis (Chapter Four), thirdly, the representativeness of the 
study sample and finally the use of direct rather than belief based measures, each 
of which will be addressed in the following section. 
5.3.1 Sample Size and Retention 
One limitation could be the numbers of participants included in the study. 
Overall recruitment was reduced by the introduction of court mandated drug 
treatments, which was an exclusion criteria throughout the thesis. Recruitment 
29 The Medical Research Council (2000) have produced a framework for the development of 
interventions in randomised controlled trials, which is worth consideration if looking to 
development an intervention for further evaluation. The framework sets out objectives to be met 
and methodological issues to consider at each stage of development. Based on five phases; pre- 
clinical/theoretical basis, modelling, exploratory trial, main trial and long term implementation, the 
framework offers researchers guidance in recognising challenges and suggests strategies for 
addressing such issues in their own trails. 
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also relied upon clinical staff, consequently referrals may have been improved if 
additional resources had been available to attend the substance misuse service on 
a more regular basis thus enabling a constant reminder of the study to clinicians. 
Bearing in mind that the population in question is hard-to-reach and 
tracking participants in longitudinal studies is a tremendous challenge, the level of 
retention in the study tries to go some way to counterbalance this problem. 
Retention rates in substance misuse treatment studies are reported to be between 
50% and 90% (Hansten et al 2000). To gain follow-up rates of 90% is a 
considerably resource intensive task and Hansten et al (2000) argues that studies 
obtaining rates of follow-up between 60-80% can produce credible findings. 
Digusto et al (2006), also report that a 70% follow-up is an acceptable rate to 
estimate overall outcomes. Thus, a retention rate of 75% over six-months, which 
included four data collection points, is certainly an acceptable follow-up rate. 
Had more participants entered the study there would have a dichotomy regarding 
numbers of participants versus levels of follow-up achievable given the limited 
resources available. 
However, to ensure adequate power as a result of the small study sample a 
reduced number of variables were used in the analysis based on the predictors of 
poor treatment outcomes discussed in the literature review in Chapter One. 
Chapters Three and Four both reported large size effects with significant findings 
from a sample size of n=57. Based on Cohen's (1992) paper "A Power Primer", 
sample size based on a power of . 80 and a significance level of 0.05, with a large 
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effect size would require a sample of n=42, for five independent variables as in 
Chapter Three and n=-47 for seven independent variables as in Chapter Four (see 
Cohen 1992, pg 158) suggesting that, although the sample is small, the study is 
adequately powered. 
53.2 Drug Treatment 
This thesis focused on heroin users accessing drug treatment as a way of 
reducing their future heroin use. Though Chapter Four found treatment per se to 
be a non-significant predictor of future heroin use, an omission in the analysis was 
the effect of treatment type on heroin outcome. For example, the type of 
medication used (methadone or buprenorphine), whether the participants were in 
maintenance treatment or undergoing detoxification and medication dosages, 
could have had an effect on outcome (Gerra et al 2003, Gossop et al 2001, 
Horspool et al 2008, West, O'Neal & Graham 2000). Consideration was given to 
this but due to the sample size, further reduction of group size by stratification 
would not have provided adequate power for this level of analysis. 
53.3 Study Sample 
The exclusion criteria used throughout the thesis included heroin users 
with severe mental health problems, alcohol dependency, homelessness and 
pregnancy thus reducing the overall representativeness heroin users accessing 
drug treatment Caution should be taken when interpreting the results gained from 
Chapters two to four as they are based on those presenting to treatment with non- 
complex presentations and as such are a sub section of heroin users attending 
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treatment services. Including heroin users with multifaceted problems may have 
yielded different salient beliefs about the difficulties relating to stopping drug use 
and different predictor variables relating to treatment attendance and ongoing 
heroin use. Future studies that include a more representative sample of heroin 
users would be desirable in order to generalise the results to a broader population. 
53.4 Belief Based Measures 
The thesis used global measures rather than belief based measures for a 
number of reasons including; evidence supporting direct measures (Armitage & 
Conner 2001), sample size and burden to participants literacy (Section 3.3.4.5 
discusses this in more detail). However, beliefs are important to develop a 
meaningful understanding about the determinants of intention and behaviour 
(Ajzenl991). Ajzen (1991), at a most basic level, explains that the behaviour is 
a function of salient information or beliefs relevant to the behaviour hence salient 
beliefs play a central role in the theory of planned behaviour. Ajzen (1991) notes 
that responding to belief items may require more careful deliberation and thus 
global measures evoke a relatively automatic response as opposed to belief items 
that may evoke a relatively reasoned response (Ajzen 1991). 
Chapter Two identifies, through qualitative interviews, that these beliefs 
are easily accessible from this population. Each participant involved in the 
qualitative study was able to give at least two salient behavioural, normative and 
control beliefs. Thus using belief based measures, in this population, could 
further improve our understanding of the facilitators and barriers to intentions and 
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behaviours and improve the predictive ability of the TPB by accurately reflecting 
the belief systems of the participants. 
5.4 Extending the Thesis: Future Considerations 
5.4.1 Additional Variables; 
Subjective norm emerged as a strong predictor of behaviour in this 
population and thus the extent to which social pressure predicts behaviour is 
significant. A further avenue of interest would be the extent to which heroin users 
connection with heroin users, and other groups, underpins the impact of subjective 
norms on intention and behaviour. In particular it would be important/useful to 
assess the extent to which they see themselves as having a 'social identity' and the 
subsequent influence on behaviour. Individuals are more likely to engage in a 
particular behaviour if it is accord with the norms of a behaviourally relevant 
group; however, if group membership is not salient then behaviour should be 
congruent with individual characteristics (Terry, Hogg & White 1999). Thus, the 
elicitation of salient normative referents is again significant in this context. 
More recent developments within social cognition research suggest that 
the TPB could be better conceptualized as a dual factor model (Conner and Sparks 
2005). Although the TPB is traditionally measured by single concepts; attitude, 
perceived behavioural control and subjective norm, Ajzen (2006) suggests that 
that each TPB component comprises two specific sub components. Thus, 
attitudes are conceptualized into having instrumental (e. g. beneficial/harmful) and 
affective (e. g. enjoyable/unenjoyable) components, perceived behavioural control 
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divided into perceived controllability (e. g. extent to which you perceive you have 
control over the behaviour) and self-efficacy (e. g. ease or difficulty of performing 
the behaviour) and social norms into injunctive (e. g. whether one believes their 
social network wants them to perform the behaviour) and descriptive norms (e. g. 
where social approval is driven by perceptions of what others do ). This is would 
seem especially salient within the social norm component where the relationship 
with intention and behaviour has generally been found to be is quite weak 
(Armitage & Conner 2001). Hence, it would be interesting to apply the dual 
factor conceptutualisation of TPB components, alongside social identity theory, to 
a heroin using population in an attempt to ftirther our understanding of heroin use 
behaviours. 
5.4.2 Interventions Designed to Elicit Change 
To gain a better understanding of how to influence heroin behaviour 
through changes in attitude, subjective norm and perceived behavioural control 
fin-ther research is needed. The identification of the salient beliefs that predict 
those variables could then underpin intervention designed to change those beliefs 
and subsequent behaviour. Research examining the use of TPB interventions 
designed to facilitate behaviour change would be of specific clinical interest 
within this context. Given that specific strategies related to the development of 
TPB intervention are sparse, the limitations highlighted in Hardeman et al (2002) 
would need to be considered and addressed. 
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5.43 Alternative Behaviours and Treatment Settings 
The application of the TPB in heroin use populations requires further 
empirical support. To the best of my knowledge this thesis is the only known 
application to this population; hence research exploring the psychosocial 
predictors of ongoing drug use is sparse. The population used in the thesis 
consisted of heroin users attending treatment services to start a medical treatment 
intervention. Hence, caution must be adopted before generalizing the findings to 
other populations of heroin or other drug users, for example those that are 
accessing services for non-medical support to stop their drug use, for example 
psychological or complementary therapies, or inpatient and residential services. 
The application of the TPB in other drug use settings would be of significance to 
improve the gencralisability of the findings. Considering one of the limitations of 
this thesis, it would also be of interest to explore the effect of different treatment 
regimes, or medications, on heroin use intention and behaviour. However, the 
present study could form the basis of future research in this area by being 
replicated using a broader sample in a range of drug treatment services. 
5.5 Conclusion 
This thesis has extended the applicability of the TPB by demonstrating 
that it is an acceptable model for use in a hard-to-reach, stigmatized population 
(heroin users). The TPB in this context accounted for moderate proportions of 
variance in intentions and behaviour and, contrary to TPB assumptions, subjective 
norm emerged as an important independent predictor of actual behaviour over and 
above intention and perceived behavioural control. 
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The thesis has overcome the TPB imitations addressed in the introduction 
by (a) utilising a longitudinal design with multiple measures over time; the TPB 
was able to predict attendance behaviour and drug use behaviours over six and 
three-months respectively and (b) using objective measures of behaviour which, 
in this domain, thus it was possible to account for between 26% and 48% of the 
variance in behaviour thus validating the predictive ability of the TPB. 
The use of combined clinical and psychosocial predictors further extends 
the applicability of the TPB by adding additional variance to the final model. The 
present thesis was limited due to sample size, nonetheless, it is the first study to 
examine the TPB within the context of heroin use and thus can provide a 
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